Astra Space Inc - Ordinary Shares (ASTR) 10-Q 5 May 22 2022 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2022	May 02, 2022	Apr. 30, 2022
Document Information [Line Items]
Document Quarterly Report	true
Document Transition Report	false
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2022
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--12-31
Entity File Number	001-39426
Entity Central Index Key	0001814329
Entity Registrant Name	ASTRA SPACE, INC.
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	1900 Skyhawk Street
Entity Address, City or Town	Alameda
Entity Address, State or Province	CA
Entity Tax Identification Number	85-1270303
Entity Address, Postal Zip Code	94501
City Area Code	866
Local Phone Number	278-7217
Title of 12(b) Security	Class A Common Stock, par value $0.0001 per share
Trading Symbol	ASTR
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Shell Company	false
Document Fiscal Period Focus	Q1
Common Class A [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding			208,614,084
Common Class B [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		55,539,188

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 161,521	$ 325,007
Marketable securities	93,669	0
Trade accounts receivable	432	1,816
inventory	8,701	7,675
Prepaid and other current assets	11,233	12,238
Total current assets	275,556	346,736
Non-current assets:
Property, plant and equipment, net	79,415	66,316
Right-of-use asset	8,979	9,079
Goodwill	58,251	58,251
Intangible assets, net	17,106	17,921
Other non-current assets	625	721
Total assets	439,932	499,024
Current liabilities:
Accounts payable	6,200	9,122
Operating lease obligation, current portion	1,790	1,704
Accrued expenses and other current liabilities	29,318	29,899
Total current liabilities	37,308	40,725
Non-current liabilities:
Operating lease obligation, net of current portion	7,039	7,180
Other non-current liabilities	27,099	14,599
Total liabilities	71,446	62,504
Commitments and Contingencies (Note 11)
STOCKHOLDERS' EQUITY (DEFICIT)
Additional paid in capital	1,862,709	1,844,875
Accumulated other comprehensive loss	(155)	0
Accumulated deficit	(1,494,096)	(1,408,383)
Total stockholders' equity	368,486	436,520
Total liabilities and stockholders' equity	439,932	499,024
Convertible Preferred Stock [Member]
STOCKHOLDERS' EQUITY (DEFICIT)
Founders convertible preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding as of March 31, 2022 and December 31, 2021	0	0
Common Class A [Member]
STOCKHOLDERS' EQUITY (DEFICIT)
Common stock Value	22	22
Common Class B [Member]
STOCKHOLDERS' EQUITY (DEFICIT)
Common stock Value	$ 6	$ 6

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2022	Dec. 31, 2021
Preferred stock, shares outstanding	0
Common stock, shares authorized	466,000,000
Convertible Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common Class A [Member]
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	400,000,000	400,000,000
Common stock, shares issued	208,610,490	207,451,107
Common stock, shares outstanding	208,610,490	207,451,107
Common Class B [Member]
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	65,000,000	65,000,000
Common stock, shares issued	55,539,188	55,539,189
Common stock, shares outstanding	55,539,188	55,539,189

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenue	$ 3,911	$ 0
Cost of Revenue	11,014	0
Gross loss	(7,103)	0
Operating expenses:
Research and development	37,927	12,196
Sales and marketing	4,764	64
General and administrative	20,986	12,394
Loss on change in fair value of contingent consideration	15,500	0
Total operating expenses	79,177	24,654
Total operating loss	(86,280)	(24,654)
Interest income (expense), net	174	(535)
Other income, net	393	0
Loss on extinguishment of convertible notes	0	(131,908)
Loss on extinguishment of convertible notes attributable to related parties	0	(1,875)
Loss before taxes	(85,713)	(158,972)
Income tax (benefit) provision	0	0
Net loss	(85,713)	(158,972)
Adjustment to redemption value on Convertible Preferred Stock	0	(1,011,726)
Net loss attributable to common stockholders	(85,713)	(1,170,698)
Common Class A [Member]
Operating expenses:
Net loss attributable to common stockholders	$ (67,657)	$ (300,913)
Net loss per share:
Weighted average number of shares – basic and diluted	208,112,630	16,206,813
Net loss per share – basic and diluted	$ (0.33)	$ (18.57)
Common Class B [Member]
Operating expenses:
Net loss attributable to common stockholders	$ (18,056)	$ (869,785)
Net loss per share:
Weighted average number of shares – basic and diluted	55,539,188	46,845,555
Net loss per share – basic and diluted	$ (0.33)	$ (18.57)

Condensed Consolidated Statemen

Condensed Consolidated Statement of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Statement of Other Comprehensive Income [Abstract]
Net loss	$ (85,713)	$ (158,972)
Other comprehensive loss
Unrealized loss on available-for-sale marketable securities	(155)	0
Total comprehensive loss	$ (85,868)	$ (158,972)

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Temporary Equity and Stockholders' Equity (Deficit) (Unaudited) - USD ($) $ in Thousands	Total	Cumulative Effect Adjustment Due To Adoption of ASU 2020-06 [Member]	Common Class A [Member]	Common Class B [Member]	Preferred Stock [Member]Convertible Preferred Stock [Member]	Preferred Stock [Member]Founders Preferred Stock [Member]	Common Stock [Member]	Common Stock [Member]Common Class A [Member]	Common Stock [Member]Common Class B [Member]	Additional Paid in Capital [Member]	Additional Paid in Capital [Member]Cumulative Effect Adjustment Due To Adoption of ASU 2020-06 [Member]	Accumulated Other Comprehensive loss [Member]	Accumulated Deficit [Member]	Accumulated Deficit [Member]Cumulative Effect Adjustment Due To Adoption of ASU 2020-06 [Member]
Beginning Balance at Dec. 31, 2020	$ (140,408)					$ 1	$ 6			$ 50,282			$ (190,697)
Beginning Balance (in shares) at Dec. 31, 2020						12,302,500	62,961,258
Temporary Equity, Beginning Balance (in shares) at Dec. 31, 2020					90,768,286
Temporary Equity, Beginning Balance at Dec. 31, 2020					$ 108,829
Stock-based compensation	2,177									2,177
Exercise of options (in shares)							498,807
Exercise of options	228									228
Issuance of Series C Convertible Preferred Stock, net of issuance costs					$ 221,943
Issuance of Series C Convertible Preferred Stock, net of issuance costs (in shares)					28,498,141
Conversion of Founders Convertible Preferred Stock to Series C Convertible Preferred Stock, issued	8,156									8,156
Conversion of Founders Convertible Preferred Stock to Series C Convertible Preferred Stock, issued (in shares)					5,073,576	(5,073,576)
Adjustment to redemption value on Convertible Preferred Stock	1,011,726		$ 260,051	$ 751,675	$ 1,011,726					51,131			960,595
Net loss	(158,972)												(158,972)
Temporary Equity, Ending Balance (in shares) at Mar. 31, 2021					124,340,003
Temporary Equity, Ending Balance at Mar. 31, 2021					$ 1,342,498
Ending Balance (in shares) at Mar. 31, 2021						7,228,924	63,460,065
Ending Balance at Mar. 31, 2021	(1,309,573)	$ (9,028)				$ 1	$ 6			(7)	$ (9,719)		(1,309,573)	$ 691
Beginning Balance at Dec. 31, 2021	436,520							$ 22	$ 6	1,844,875			(1,408,383)
Beginning Balance (in shares) at Dec. 31, 2021								207,451,107	55,539,189
Stock-based compensation	$ 17,041								$ (1)	17,041
Exercise of options (in shares)	176,774
Issuance Of Common Stock Under Equity Plans, Shares								1,159,383
Issuance Of Common Stock Under Equity Plans	$ 793									793
Adjustment to redemption value on Convertible Preferred Stock			$ 0	$ 0
Unrealized loss on available-for-sale marketable securities	(155)											$ (155)
Net loss	(85,713)												(85,713)
Ending Balance (in shares) at Mar. 31, 2022								208,610,490	55,539,188
Ending Balance at Mar. 31, 2022	$ 368,486							$ 22	$ 6	$ 1,862,709		$ (155)	$ (1,494,096)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net loss	$ (85,713)	$ (158,972)
Adjustments to reconcile net loss to cash flows used in operating activities
Stock-based compensation	17,041	10,333
Depreciation	1,960	888
Amortization of intangible assets	815	0
Inventory net realizable value write downs	5,500	0
Non-cash lease expense	352	170
Accretion (amortization) of marketable securities purchased at a premium (discount)	67	0
Loss on change in fair value of contingent consideration	15,500	0
Loss on extinguishment of convertible notes	0	131,908
Loss on extinguishment of convertible notes attributable to related parties	0	1,875
Amortization of convertible note discounts	0	315
Amortization of convertible note discounts attributable to related parties	0	55
Trade accounts receivable	1,383	0
Inventories	(6,526)	(370)
Prepaid and other current assets	1,005	(4,213)
Other non-current assets	97	0
Accounts payable	125	734
Lease liabilities	(306)	73
Accrued expenses and other current liabilities	(72)	3,330
Other non-current liabilities	498	197
Net cash used in operating activities	(48,274)	(13,677)
Cash flows from investing activities:
Acquisition of trademark	(850)	(3,200)
Purchases of marketable securities	(93,891)	0
Purchases of property, plant and equipment	(20,942)	(324)
Net cash used in investing activities	(115,683)	(3,524)
Cash flows from financing activities:
Proceeds from issuance of Series C preferred stock	0	30,000
Issuance cost of Series C preferred stock	0	(90)
Repayments on term loans	0	(300)
Repayments on equipment advances	0	(700)
Proceeds from stock issued under equity plans	79	228
Proceeds from Employee Stock Purchase Plan	392	0
Net cash provided by financing activities	471	29,138
Net increase (decrease) in cash and cash equivalents	(163,486)	11,937
Cash and cash equivalents at beginning of period	325,007	10,611
Cash and cash equivalents at end of period	161,521	22,548
Non-cash activities:
Assets acquired included in accounts payable and accrued expenses and other current liabilities	3,252	492
Change in redemption value of Convertible Preferred Stock		1,011,726
Supplemental disclosures of cash flow information:
Cash paid for interest	$ 0	$ 80

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Description of Business, Basis of Presentation and Significant Accounting Policies	Note 1 — Description of Business, Basis of Presentation and Significant Accounting Policies Description of Business Astra Space, Inc. designs, tests, manufactures and operates the next generation of launch services and space services and products that it expects to enable a new generation of global communications, earth observation, precision weather monitoring, navigation, and surveillance capabilities. Astra Space, Inc.'s mission is to Improve Life on Earth from Space TM through greater connectivity and more regular observation and to enable a wave of innovation in low Earth orbit by expanding our space platform offerings. Holicity Inc. (“Holicity”) was originally incorporated in Delaware and was established as a special purpose acquisition company, which completed its initial public offering in August 2020. On June 30, 2021 (the “Closing Date”), Holicity consummated a business combination (the “Business Combination”) pursuant to the Business Combination Agreement dated as of February 2, 2021 (the “BCA”), by and among Holicity, Holicity Merger Sub Inc., a wholly owned subsidiary of Holicity (“Merger Sub”), and Astra Space Operations, Inc. (“pre-combination Astra”). Immediately upon the consummation of the Business Combination, Merger Sub merged with and into pre-combination Astra with pre-combination Astra surviving the merger as a wholly owned subsidiary of Holicity. Holicity changed its name to “Astra Space, Inc.” and pre-combination Astra changed its name to “Astra Space Operations, Inc.” Unless the context otherwise requires, “we”, “us”, “our”, “Astra” and the “Company” refers to Astra Space, Inc., the combined company and its subsidiaries following the Business Combination and Astra Space Operations, Inc. prior to the Business Combination. See Note 3 — Acquisitions for further discussion of the Business Combination. The Company’s Class A common stock is listed on the Nasdaq under the symbol “ASTR”. Basis of Presentation and Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of Astra and its subsidiaries, and have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) as determined by the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for financial reporting. The condensed consolidated financial statements included herein are unaudited, and reflect all adjustments which are, in the opinion of management, of a normal recurring nature and necessary for a fair statement of the results for the periods presented. The December 31, 2021 condensed consolidated balance sheet data were derived from Astra’s audited consolidated financial statements included in its Annual Report on Form 10-K for year ended December 31, 2021 as filed with the SEC. All intercompany transactions and balances have been eliminated in consolidation. The operating results for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022, or for any other future period. Business Combination On June 30, 2021, the Business Combination pursuant to the BCA, by and among Holicity, Merger Sub, and pre-combination Astra, was accounted for as a reverse recapitalization as pre-combination Astra was determined to be the accounting acquirer under ASC 805. The determination is primarily based on the evaluation of the following facts and circumstances: • the equity holders of pre-combination Astra hold the majority of voting rights in the Company; • the board of directors of pre-combination Astra represent a majority of the members of the board of directors of the Company; • the senior management of pre-combination Astra became the senior management of the Company; and • the operations of pre-combination Astra comprise the ongoing operations of the Company. In connection with the Business Combination, outstanding common stock and preferred convertible stock of the pre-combination Astra was converted into common stock of the Company, par value of $ 0.0001 per share, representing a recapitalization, and the net assets of the Company were acquired and recorded at historical cost, with no goodwill or intangible assets recorded. Pre-combination Astra was deemed to be the predecessor and the condensed consolidated assets and liabilities and results of operations prior to the Closing Date are those of pre-combination Astra. Reported shares and earnings per share available to common stockholders, prior to the Business Combination, have been retroactively restated as shares reflecting the exchange ratio established in the BCA. The number of shares of preferred stock was also retroactively restated based on the exchange ratio. See Note 3 — Acquisitions for additional information. Liquidity The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis. The Company has historically funded its operations primarily by equity financings and convertible promissory notes prior to the Business Combination and subsequently funded its operations through cash proceeds obtained as part of the Business Combination and related private placement. As of March 31, 2022, the Company’s existing sources of liquidity included cash and cash equivalents of $ 161.5 million and marketable securities of $ 93.7 million. The Company has a limited history of operations and has incurred negative cash flows from operating activities and loss from operations in the past as reflected in the accumulated deficit of $ 1,494.1 million as of March 31, 2022. The Company expects to continue to incur operating losses due to the investments it intends to make in its business, including the development of its products and services. Management continuously evaluates opportunities to strengthen the Company’s financial position, including through the issuance of additional equity securities or by entering into new financing arrangements, as appropriate. However, the Company has adequate liquidity that it expects will be sufficient to fund operating and capital expenditure requirements through at least twelve (12) months from the date of issuance of these financial statements. Impact of the COVID-19 Pandemic The Company has been actively monitoring the ongoing COVID-19 pandemic situation and its impact on the Company’s business. The COVID-19 pandemic had disrupted everyday life and markets worldwide, leading to significant business and supply-chain disruption, as well as broad-based changes in supply and demand. The Company has been diligent in testing and monitoring our employees, and there have been disruptions in productivity, although these disruptions have not resulted in suspension of our manufacturing facilities. However, beginning in the first quarter of 2021, there has been a trend in many parts of the world of increasing availability and administration of vaccines against COVID-19, as well as an easing of restrictions on social, business, travel and government activities and functions. On the other hand, infection rates and regulations continue to fluctuate in various regions and there are ongoing global impacts resulting from the pandemic, including challenges and increases in costs for logistics and supply chains, such as increased intermittent supplier delays and a shortfall of semiconductor supply. Ultimately, we cannot predict the duration of the COVID-19 pandemic. We will continue to monitor macroeconomic conditions to remain flexible and to optimize and evolve our business as appropriate and deploy our production, workforce and other resources accordingly. Use of Estimates and Judgements The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities in the condensed consolidated financial statements and accompanying notes. The Company bases these estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ significantly from those estimates. Significant items subject to such estimates and assumptions include the valuation of goodwill and intangible assets, inventory valuation, stock-based compensation, pre-combination Astra common stock, useful lives of intangible assets and fixed assets, deferred tax assets, income tax uncertainties, contingent consideration and other contingencies. Significant Accounting Policies Other than those described below, there have been no changes to the Company’s significant accounting policies described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, that have had a material impact on its unaudited condensed consolidated financial statements and related notes. Marketable securities. Marketable securities consist of U.S. Treasury securities, corporate debt securities, commercial paper, and asset backed securities. The Company classifies marketable securities as available-for-sale at the time of purchase and reevaluates such classification as of each balance sheet date. Interest receivable on these securities is presented in other current assets on the condensed consolidated balance sheets. All marketable securities are recorded at their estimated fair values. When the fair value of a marketable security declines below its amortized cost basis, the carrying value of the security will be reduced to its fair value if it is more likely than not that management is required to sell the impaired security before recovery of its amortized basis, or management has the intention to sell the security. If neither of these conditions are met, the Company determines whether any portion of the decline is due to credit losses. Any portion of that decline attributable to credit losses, to the extent expected to be nonrecoverable before the sale of the security, is recognized in the Company’s condensed consolidated statement of operations. When the fair value of the security declines below its amortized cost basis due to changes in interest rates, such amounts are recorded in accumulated other comprehensive income (loss) and are recognized in the Company’s condensed consolidated statement of operations only if the Company sells or intends to sell the security before recovery of its cost basis. Realized gains and losses are determined based on the specific identification method and are reported in other income (expense), net in the Company’s condensed consolidated statements of operations.

Revenues

Revenues	3 Months Ended
	Mar. 31, 2022
Revenues [Abstract]
Revenues	Note 2 — Revenues The Company recognizes revenue to reflect the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. Through its current and anticipated offerings, the Company expects to generate revenue by providing the following goods or services: Launch Services — To provide rapid, global, and affordable launch services to satellite operators and governments in partnership with third-party spaceport providers globally. Our launch services include services tied directly to our launch along with complementary services that are not part of our fixed pricing for which we charge a separate fee. The Company currently operates its launches from Pacific Spaceport Complex in Kodiak, Alaska and Cape Canaveral Space Force Station in Cape Canaveral, Florida. The Company plans to add additional launch sites in diverse locations based on its customers' inclination requirements and as the Company increases the frequency of launches. Space Products — To design and provide space products based on the customers' needs for a successful satellite launch and other products that the Company may sell in the future. Currently the Company offers two in-space electric propulsion systems. Space Services — To invest in building the Company's portfolio of space services, which includes communication service and constellation services, which will be based on the Company's network of spacecraft that customers can access for use in their business. Specifically, the Company's space services encompass all aspects of hosted satellite and constellation services, including hosting customer payloads onto its spacecraft, and delivering services, such as communication and other services, to customers from its space platform. As of March 31, 2022, the Company has only entered into contracts for launch services and space products. As of March 31, 2022, the Company is in early stages of developing its space services offerings which includes communication service and constellation services. The Company’s contracts may provide customers with termination for convenience clauses, which may or may not include termination penalties. In some contracts, the size of the contractual termination penalty increases closer to the scheduled launch date. At each balance sheet date, the Company evaluates each contract’s termination provisions and the impact on the accounting contract term, i.e., the period in which the Company has enforceable rights and obligations. This includes evaluating whether there are termination penalties and if so, whether they are considered substantive. The Company applies judgment in determining whether the termination penalties are substantive. Recognition of Revenue The work performed by the Company in fulfilling launch services and space products performance obligations is not expected to create an asset to the customer since the launch vehicle that is built to deliver the customer’s payload into orbit will not be owned by the customer or the propulsion systems that are built to thrust the customers' satellite into orbit will not be owned by the customer until they are delivered to the customer. The Company recognizes revenue at a point in time upon satisfaction of the performance obligations under its launch services and space products agreements . The Company recognized $ 3.9 million of revenues for the three months ended March 31, 2022 under its launch services agreements. No revenue had been recognized for the three months ended March 31, 2021. Contracts with governmental entities involving research and development milestone activities do not represent contracts with customers under ASC 606 and as such, amounts received are recorded in other income (expense), net in the condensed consolidated statements of operations. The Company recorded $ 0.4 million for the three months ended March 31, 2022. No such income was recorded for the three months ended March 31, 2021. Contract Balances and Remaining Performance Obligations Contract balances. Contract assets and liabilities represent the differences in the timing of revenue recognition from the receipt of cash from the Company’s customers and billings. Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. Receivables represent rights to consideration that are unconditional. Such rights are considered unconditional if only the passage of time is required before payment of that consideration is due. The Company had no contract assets as of March 31, 2022 and December 31, 2021. The Company had contract liabilities of $ 10.5 million and $ 10.4 million as of March 31, 2022 and December 31, 2021, respectively. The Company recognized revenue of $ 2.3 million during the three months ended March 31, 2022 that was included in the contract liabilities balance at the beginning of the period. No revenue was recognized for the three months ended March 31, 2021. Remaining performance obligations . Revenue allocated to remaining performance obligations represents the transaction price allocated to the performance obligations that are unsatisfied, or partially unsatisfied. It includes unearned revenue and amounts that will be invoiced and recognized as revenue in future periods and does not include contracts where the customer is not committed. Customers are not considered committed when they are able to terminate their contractual obligations to us without payment of a substantive penalty under the contract. Many of the Company’s contracts allow the customer to terminate the contract prior to launch or delivery without a substantive penalty, and therefore the enforceable contract is for a period less than the stated contractual term. Further, the Company has elected not to disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less. The Company had unsatisfied performance obligations of $ 23.8 million as of March 31, 2022, the majority of which is expected to be recognized in 2022 .

Acquisitions

Acquisitions	3 Months Ended
	Mar. 31, 2022
Business Combinations [Abstract]
Acquisitions	Note 3 — Acquisitions Acquisition of Apollo Fusion, Inc. On July 1, 2021, or the Apollo Acquisition Date, the Company, through its wholly owned indirect subsidiary, merged with Apollo Fusion, Inc. ("Apollo"). The results of Apollo’s operations have been included in the unaudited condensed consolidated financial statements since that date. Apollo designs, tests, manufactures and operates propulsion modules to enable satellites to orbit in space. The fair value of the consideration paid as of July 1, 2021, was $ 70.8 million, net of cash acquired (the "Apollo Merger"), which consisted of the following: Purchase Consideration (in thousands) Cash paid for outstanding Apollo common stock and options $ 19,926 Fair value of Astra Class A common stock issued 33,008 Fair value of contingent consideration 18,400 Total purchase consideration 71,334 Less: cash acquired 566 Total purchase consideration, net of cash acquired $ 70,768 The fair value of the shares of Class A common stock issued in the Apollo Merger was determined based on the closing market price of the Company’s Class A common stock on the Apollo Acquisition Date. The vesting of all unvested stock options of Apollo granted prior to the Apollo Acquisition Date were accelerated prior to the acquisition and were then cancelled in exchange for a right of each option-holder to cash, equity and contingent consideration based on their pro-rata percentage, assuming all stock options of Apollo had been exercised. The contingent consideration requires the Company to pay $ 75.0 million of additional consideration to Apollo’s former shareholders and option-holders, if Apollo meets certain customer revenue related milestones over a two and half year period ending on December 31, 2023. The contingent consideration is earned, which is a combination of total contract value and relevant payout ratio, if the contract with the customer is entered into after the acquisition date and 25 % of revenue under the contract is recognized by December 31, 2023 under ASC 606. Contingent consideration is payable on a quarterly basis based on the milestones achieved. The fair value of the contingent consideration arrangement at the acquisition date was $ 18.4 million. The Company estimated the fair value of the contingent consideration using a Monte Carlo simulation model. This fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement as defined in ASC 820. As of March 31, 2022, the contingent consideration recognized increased to $ 29.2 million as a result of changes in forecasted revenues subject to milestone payments and the passage of time. The Company has recognized $ 10.8 million in cumulative net losses on changes in fair value of contingent consideration from the Apollo Acquisition Date, of which $ 15.5 million in loss was recognized in the condensed consolidated statement of operations for the three months ended March 31, 2022. An additional $ 10.0 million of cash ("Cash Earnout") will be paid to employees of Apollo that joined Astra, subject to certain vesting conditions, as amended. The Cash Earnout is accounted for as compensation expense over the requisite service period in the post-acquisition period as the payment is subject to the employee's continued employment with the Company. The Company has recognized $ 7.1 million in compensation cost from the Apollo Acquisition Date, of which $ 1.3 million in compensation cost was recognized in research and development expense in the condensed consolidated statement of operations for the three months ended March 31, 2022. The earned, but unpaid, amount of the Cash Earnout of $ 3.4 million and $ 3.9 million is recorded within accrued expenses and other current liabilities in the condensed consolidated balance sheet as of March 31, 2022 and December 31, 2021, respectively. In addition, the Company awarded 1,047,115 Performance Stock Units ("PSUs") to employees of Apollo that joined Astra, subject to certain performance-based milestones, as amended, and other vesting provisions. The PSUs are accounted for as compensation expense over the requisite service period in the post-acquisition period as the vesting of PSUs is subject to time-based and performance-based vesting conditions. See Note 15 — Stock-based Compensation for additional information. We allocated the fair value of the purchase consideration to the tangible assets, liabilities and intangible assets acquired, based on their fair values. The excess purchase price over those fair values is recorded as goodwill. Our valuation assumptions of acquired assets and assumed liabilities require significant estimates, especially with respect to intangible assets. The final purchase consideration allocation is presented in the following table. (in thousands) Fair Value Inventory $ 131 Prepaid and other current assets 796 Property, plant and equipment 996 Right of use assets 163 Goodwill 58,251 Intangible assets 15,350 Other non-current assets 75 Total assets acquired 75,762 Accounts payable ( 950 ) Accrued expenses and other current liabilities ( 1,939 ) Operating lease obligation ( 163 ) Other non-current liabilities ( 1,942 ) Total liabilities assumed ( 4,994 ) Fair value of net assets acquired $ 70,768 Goodwill is primarily attributable to the assembled workforce and anticipated synergies expected from the integration of the Apollo business. The synergies include operating efficiencies, and other strategic benefits projected to be achieved as a result of the Apollo Merger. Goodwill is not deductible for tax purposes. There were no revenues recorded during the three months ended March 31, 2022 related to Apollo. It was impracticable to determine the effect on net income attributable to Apollo as we had integrated a substantial portion of Apollo into our ongoing operations during the year. Intangible Assets Fair Value Weighted-Average Amortization Periods (in thousands) (in years) Developed technology $ 12,100 6 Customer contracts and related relationships 2,900 3 Order backlog 200 1 Tradename 150 2 Total identified intangible assets $ 15,350 Developed technology relates to propulsion modules. The Company valued the developed technology using the relief-from-royalty method under the income approach. This method is based on the application of a royalty rate to forecasted revenue that are expected to be generated by developed technology. The economic useful life was determined based on the technology cycle related to the developed technology, as well as the cash flows over the forecast period. Customer contracts and related relationships represent the fair value of future projected revenue that will be derived from sales of products to existing customers of Apollo. Customer contracts and related relationships were valued using the multi-period excess earnings method under the income approach. This method reflects the present value of the projected cash flows that are expected to be generated by the customer contracts and related relationships less charges representing the contribution of other assets to those cash flows. The economic useful life was determined based on historical customer turnover rates. Order backlog represents business under existing contractual obligations. The fair value of backlog was determined using the multi-period excess earnings method under the income approach based on expected operating cash flows from future contractual revenue. The economic useful life was determined based on the expected life of the backlog and the cash flows over the forecast period. Trade name relates to the “Apollo” trade name. The fair value was determined by applying the relief-from-royalty method under the income approach. This method is based on the application of a royalty rate to forecasted revenue under the trade name. The economic useful life was determined based on the expected life of the trade name and the cash flows anticipated over the forecast period. The Company believes the amounts of purchased intangible assets recorded above represent the fair values of, and approximate the amounts a market participant would pay for, these intangible assets as of the Apollo Acquisition Date. Reverse Recapitalization. On June 30, 2021, pre-combination Astra Space, Inc. and Holicity Inc. consummated the Business Combination contemplated by the BCA, with pre-combination Astra surviving the merger as a wholly owned subsidiary of Holicity. Upon consummation of the Business Combination, Holicity changed its name to Astra Space, Inc., and pre-combination Astra changed its name to Astra Space Operations, Inc. Immediately following the Business Combination, there were 198,090,903 shares of Class A common stock and 56,239,189 shares of Class B common stock issued and outstanding with a par value of $ 0.0001 . Additionally, there were outstanding options to purchase an aggregate of 5,993,412 shares of Class A common stock and outstanding warrants to purchase 15,813,829 shares of Class A common stock. The Business Combination was accounted for as a reverse recapitalization in accordance with GAAP as pre-combination Astra has been determined to be the accounting acquirer. Under this method of accounting, while Holicity was the legal acquirer, it has been treated as the “acquired” company for financial reporting purposes. Accordingly, the Business Combination was treated as the equivalent of pre-combination Astra issuing stock for the net assets of Holicity, accompanied by a recapitalization. The net assets of Holicity were stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the Business Combination are those of pre-combination Astra. Reported shares and earnings per share available to holders of the Company’s common stock, prior to the Business Combination, have been retroactively restated as shares reflecting the exchange ratio established in the BCA ( approximately one pre-combination Astra share to 0.665 of the Company's shares ). The most significant change in the post-combination Company’s reported financial position and results was an increase in cash, net of transactions costs, of $ 463.6 million, including $ 200.0 million in gross proceeds from the private placements (the “PIPE”). In connection with the Business Combination, $ 25.2 million of transaction costs were paid on the Closing Date. Additionally, on the Closing Date, the Company repaid all the outstanding debt except for Paycheck Protection Program note. Refer to Note 6 – Long-term Debt. Upon closing of the Business Combination, the shareholders of Holicity, including Holicity founders, were issued 37,489,019 shares of Class A common stock. In connection with the Closing, holders of 10,981 shares of common stock of Holicity were redeemed at a price per share of $ 10.00 . In connection with the Closing 20,000,000 shares were issued to PIPE investors at a price per share of $ 10.00 . The number of shares of Class A common stock issued immediately following the consummation of the Business Combination were: Common stock of Holicity 29,989,019 Holicity founder shares 7,500,000 Shares issued in PIPE 20,000,000 Business Combination and PIPE shares 57,489,019 Pre-combination Astra shares 140,601,884 Total shares of Class A common stock immediately after Business Combination 198,090,903 In addition, in connection with the consummation of the Business Combination, 56,239,189 shares of Class B common stock were issued to two executive officers and founders of the Company: Chris Kemp and Adam London in exchange for an aggregate 73,699,647

Supplemental Financial Informat

Supplemental Financial Information	3 Months Ended
	Mar. 31, 2022
Supplemental Financial Information Abstract
Supplemental Financial Information	Note 4 — Supplemental Financial Information Inventories in thousands As of March 31, 2022 As of December 31, 2021 Raw materials $ 8,032 $ 5,775 Work in progress 669 941 Finished goods — 959 Inventories $ 8,701 $ 7,675 There were $ 5.5 million of inventory net realizable value write downs recorded within cost of revenues during the three months ended March 31, 2022. There were no inventory net realizable value write downs recorded during the three months ended March 31, 2021. Property, Plant and Equipment, net Presented in the table below are the major classes of property, plant and equipment: in thousands As of March 31, 2022 As of December 31, 2021 Construction in progress $ 9,693 $ 39,246 Computer and software 3,418 3,092 Leasehold improvements 54,343 14,177 Research equipment 11,716 8,935 Production equipment 11,746 10,442 Furniture and fixtures 1,035 1,001 Total property, plant and equipment 91,951 76,893 Less: accumulated depreciation ( 12,536 ) ( 10,577 ) Property, plant and equipment, net $ 79,415 $ 66,316 Depreciation expense amounted to $ 2.0 million and $ 0.9 million for the three months ended March 31, 2022 and 2021, respectively. No impairment charges were recorded for the three months ended March 31, 2022 and 2021. Accrued Expenses and Other Current Liabilities in thousands As of March 31, 2022 As of December 31, 2021 Employee compensation and benefits $ 6,516 $ 9,927 Contract liabilities, current portion 10,307 10,162 Fair value of contingent consideration, current portion 3,500 — Construction in progress related accruals 1,365 3,726 Accrued expenses 4,837 3,464 Other (miscellaneous) 2,793 2,620 Accrued expenses and other current liabilities $ 29,318 $ 29,899 Other Non-Current Liabilities in thousands As of March 31, 2022 As of December 31, 2021 Fair value of contingent consideration, net of current portion $ 25,700 $ 13,700 Contract liabilities, net of current portion 149 149 Other (miscellaneous) 1,250 750 Other non-current liabilities $ 27,099 $ 14,599

Intangible Assets

Intangible Assets	3 Months Ended
	Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Note 5 — Intangible Assets in thousands Carrying Amount Accumulated Amortization Net Book Value As of March 31, 2021: Definite-lived intangible assets Developed technology $ 12,100 $ 1,513 $ 10,587 Customer contracts and related relationship 2,900 725 2,175 Order backlog 200 150 50 Trade names 150 56 94 Intangible assets subject to amortization 15,350 2,444 12,906 Indefinite-lived intangible assets Trademarks 4,200 — 4,200 Total $ 19,550 $ 2,444 $ 17,106 in thousands Carrying Amount Accumulated Amortization Net Book Value As of December 31, 2021: Definite-lived intangible assets Developed technology $ 12,100 $ 1,008 $ 11,092 Customer contracts and related relationship 2,900 483 2,417 Order backlog 200 100 100 Trade names 150 38 112 Intangible assets subject to amortization 15,350 1,629 13,721 Indefinite-lived intangible assets Trademarks 4,200 — 4,200 Total $ 19,550 $ 1,629 $ 17,921 Based on the amount of intangible assets as of March 31, 2022, the expected amortization expense for each of the next five years and thereafter is as follows: in thousands Expected Amortization Expense 2022 (remainder) $ 2,343 2023 3,021 2024 2,500 2025 2,017 2026 2,017 Thereafter 1,008 Total intangible assets $ 12,906

Long-term Debt

Long-term Debt	3 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
Long-Term Debt	Note 6 — Long-Term Debt There is no short-term and long-term debt outstanding as of March 31, 2022 and December 31, 2021. In connection with the Business Combination, all outstanding debt with the exception of the Paycheck Protection Program note was paid on June 30, 2021. Refer to Note – 3 Acquisitions. In August 2021, the Company's application for forgiveness of Paycheck Protection Program was approved in the full amount of the outstanding principal balance and accrued interest. Term Loan and Equipment Advances On December 25, 2018, the Company entered into a loan agreement (the “2018 Loan Agreement”) with Silicon Valley Bank (“SVB”). Pursuant to the 2018 Loan Agreement, the Company could borrow up to a total of $ 3.0 million term loans (“2018 Term Loans”) and $ 7.0 million equipment loans (“2018 Equipment Advances”) with access period ended on April 30, 2020 for 2018 Term Loans and June 30, 2019 for 2018 Equipment Advances. Amounts borrowed under the 2018 Loan Agreement were repaid prior to or on June 30, 2021. In connection with the execution of the 2018 Loan Agreement, the Company entered into a 2018 warrant agreement which granted certain warrants to SVB (the “Warrants”). The Warrants were issued in one initial tranche on December 25, 2018 and three subsequent tranches in 2019 each time the Company made an additional debt draw under the 2018 Loan Agreement. Pursuant to the warrant agreement, SVB had the option to purchase an aggregate of 480,520 shares of Class A common stock. The warrants had a weighted average exercise price of $ 0.24 per share and were exercisable for a period of 10 years. The Company accounted for all the Warrants issued as equity instruments since the Warrants were indexed to the Company’s common shares and met the criteria for classification in stockholders’ equity. In July 2021, SVB exercised all the outstanding Warrants and the Company issued 472,113 shares of Company's Class A Common Stock, net of exercise price. Paycheck Protection Program Note (“PPP Note”) On April 20, 2020, the Company received loan proceeds of approximately $ 4.9 million under the Paycheck Protection Program (“PPP”), offered by the U.S. Small Business Administration (the “SBA”) pursuant to Title 1 of the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”). The PPP Note proceeds were available to be used to pay for payroll costs, including salaries, commissions, and similar compensation, group health care benefits, and paid leaves, rent and utilities, and mortgage interest payments. The PPP Note was subject to forgiveness to the extent proceeds were used for payroll costs, including payments required to continue group health care benefits, and certain rent, utility, and mortgage interest expenses (collectively, “Qualifying Expenses”), pursuant to the terms and limitations of the PPP Note. The Company used the PPP Note amount intended for Qualifying Expenses. In the first quarter of the year ended December 31, 2021, the Company submitted a forgiveness application to its lender seeking full forgiveness of the PPP Note. On August 24, 2021, the Company received notice from the lender that the Small Business Administration has approved the application for forgiveness of the PPP Note in the full amount. Convertible Notes Issuance of Convertible Notes From June 2019 through July 2019, the Company issued $ 14.8 million of convertible promissory notes (the “June 2019 Convertible Notes”) to certain investors. The June 2019 Convertible Notes matured on June 10, 2021 and accrued interest at 2.37 % or 2.13 %, compounded annually on basis of 360-days year of twelve 30-day months. Principal and any accrued but unpaid interest were due and payable at maturity. From October 2019 through December 2020, the Company issued $ 45.0 million of convertible promissory notes (the “October 2019 Convertible Notes” and collectively with the June 2019 Convertible Notes, the “Convertible Notes”) to certain investors. The October 2019 Convertible Notes matured on October 1, 2021 and accrued interest at 1.69 %, 1.59 % or 1.85%, compounded annually on basis of 360-days year of twelve 30-day months. Principal and any accrued but unpaid interest were due and payable at maturity. Settlement of Convertible Notes On January 28, 2021, the Company entered a stock purchase agreement with certain investors to close the issuance of Series C convertible preferred stock at a cash purchase price of $ 6.62 per share and settle all outstanding Convertible Notes through Series C convertible preferred stock at a conversion price of $ 1.33 or $ 1.71 per share (“Series C Financing”). The Company issued 38,323,292 shares of Series C Convertible Preferred Shares (pre-combination) for conversion of outstanding Convertible Notes of $ 61.0 million. The June 2019 Convertible Notes were settled pursuant to the contractual conversion upon the Next Equity Financing feature with such financing yielding at least $ 20 million in a single transaction. The Company credited the net carrying amount of the June 2019 Convertible Notes of $ 14.5 million, including any unamortized debt discount, to Series C convertible preferred stock with no gain or loss recognized. The October 2019 Convertible Notes were settled based on negotiated terms between the Company and the note holders as the Series C Financing did not meet the definition of Next Equity Financing for the October 2019 Convertible Notes. The Company assessed the economics of the settlement of the October 2019 Convertible Notes and concluded that it should be treated as a privately negotiated debt redemption/settlement transaction where debt extinguishment accounting should be applied. Therefore, the Company derecognized the net carrying amount, including any unamortized debt discount, of the October 2019 Convertible Notes of $ 42.6 million and recognized the Series C convertible preferred stock issued specifically to settle the October 2019 Convertible Notes at fair value as the reacquisition consideration. Accrued and unpaid interest of $ 0.6 million was settled and not paid in cash and therefore it was included in calculating the extinguishment loss. The difference between the net carrying amount of the October 2019 Convertible Notes, plus accrued and unpaid interest, and the reacquisition consideration was recorded as a loss on extinguishment in the condensed consolidated statement of operations for the three months ended March 31, 2021. The Company issued in aggregate 26,727,308 shares of Series C convertible preferred stock (pre-combination) to settle the October 2019 Convertible Notes. The fair value of the Series C convertible preferred stock was determined to be $ 176.9 million using the cash purchase price of $ 6.62 per share on January 28, 2021. These October 2019 Convertible Notes had a carrying amount plus accrued and unpaid interest of $ 43.2 million upon settlement. The difference of $ 133.8 million was recognized as a loss on extinguishment on the Company’s condensed consolidated statement of operations for the three months ended March 31, 2021.

Warrant Liabilities

Warrant Liabilities	3 Months Ended
	Mar. 31, 2022
Disclosure Text Block [Abstract]
Warrant Liabilities Text Block	Note 7 — Warrant Liabilities As part of Holicity’s initial public offering ("IPO") in 2020, Holicity issued 9,999,976 warrants to third party investors, and each whole warrant entitled the holder to purchase one share of the Company's Class A common stock at an exercise price of $ 11.50 per share (the “Public Warrants”). Simultaneously with the closing of the IPO, Holicity completed the private sale of 5,333,333 warrants to Holicity’s sponsor (“Private Placement Warrants”) and each Private Placement Warrant allowed the sponsor to purchase one share of the Company's Class A common stock at $ 11.50 per share. The Private Placement Warrants and the shares of common stock issuable upon the exercise of the Private Placement Warrants were not transferable, assignable or salable until after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants were exercisable for cash or on a cashless basis, at the holder’s option, and were non-redeemable so long as they were held by the initial purchasers or their permitted transferees. If the Private Placement Warrants were held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrant. The Company accounted for Public Warrants and Private Placement Warrants as liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in FASB ASC 480, Distinguishing Liabilities from Equity ("ASC 480") and ASC 815, Derivatives and Hedging ("ASC 815"). Specifically, the exercise of the Public and Private Placement Warrants may be settled in cash upon the occurrence of a tender offer or exchange that involves 50 % or more of the Company’s Class A shareholders. Because not all of the Company’s shareholders needed to participate in such tender offer or exchange to trigger the potential cash settlement and the Company did not control the occurrence of such an event, the Company concluded that the Public Warrants and Private Placement Warrants did not meet the conditions to be classified in equity. Since the Public and Private Placement Warrants met the definition of a derivative under ASC 815, the Company recorded these warrants as liabilities on the balance sheet at fair value upon the closing of the Business Combination, with subsequent changes in their respective fair values recognized in the consolidated statement of operations at each reporting date. On November 26, 2021, the Company issued a notice of redemption to redeem all of its Public Warrants and Private Placement Warrants ("Redeemable Warrants") outstanding as of December 27, 2021. Under the Warrant Agreement, the Company was entitled to redeem not less than all of the outstanding Redeemable Warrants at a Redemption Price of $ 0.10 per Redeemable Warrant, provided that the last reported sales price of the Class A common stock had been at least $ 10.00 per share on the trading day prior to the date on which notice of redemption is given, and further provided that there is an effective registration statement covering the shares of Class A common stock issuable upon exercise of the Redeemable Warrants and a current prospectus relating thereto, available through the Redemption Date. Under the notice of redemption, Company required holders of the Redeemable Warrants to exercise their Warrants on a cashless basis, (the “Cashless Exercise Option”) and holders were not permitted to exercise Redeemable Warrants by paying the $ 11.50 per share exercise price in cash. Pursuant to the Cashless Exercise Option, an exercising holder of the Redeemable Warrants received a number of shares of Class A common stock (the “Exercise Shares”) equal to the quotient obtained by dividing the product of the number of shares of Class A common stock underlying the Redeemable Warrants, multiplied by the excess of the fair market value of the Class A common stock over the exercise price of the Redeemable Warrants by the fair market value. Since the fair market value was less than the exercise price of the Redeemable Warrants, no Exercise Shares would have been issued if a holder would have elected to exercise its Redeemable Warrant pursuant to the Cashless Exercise Option. Alternatively, holders of the Redeemable Warrants were entitled to elect to receive, in lieu of the redemption price or exercising their Redeemable Warrants pursuant to the Cashless Exercise Option, 0.2560374 shares of Class A common stock for each Redeemable Warrants. In connection with the redemption, the holders of 9,413,895 Public Warrants and 5,333,333 Private Placement Warrants elected to receive, in lieu of the redemption price, an aggregate 3,775,709 shares of Class A common stock at 0.2560374 shares of Class A Common Stock per Warrant. A total of 586,075 Public Warrants remained unexercised as of December 27, 2021 and the Company redeemed the Public Warrants for a redemption price of $ 0.10 per Redeemable Warrant on December 27, 2021.

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Note 8 — Income Taxes We compute our provision for income taxes by applying the estimated annual effective tax rate to year-to-date income from recurring operations and adjust the provision for discrete tax items recorded in the period. There has historically been no federal or state provision for income taxes because the Company has incurred operating losses and maintains a full valuation allowance against its net deferred tax assets. For the three months ended March 31, 2022 and 2021, the Company recognized no provision for income taxes consistent with the losses incurred and the valuation allowance against the deferred tax assets. Utilization of net operating loss carryforwards, tax credits and other attributes may be subject to future annual limitations due to the ownership change limitations provided by Section 382 of the Internal Revenue Code and similar state provisions. The Company files income tax returns in the U.S. federal jurisdiction and various states. The Company is not currently under examination by income tax authorities in federal, state or other jurisdictions. All tax returns will remain open for examination by the federal and state authorities for three and four years, respectively, from the date of utilization of any net operating loss or credits.

Leases

Leases	3 Months Ended
	Mar. 31, 2022
Leases [Abstract]
Leases	Note 9 — Leases The Company has operating leases for warehouse, production, and office facilities and equipment. Lease contracts have remaining lease terms of less than one year to seven years , some of which include options to extend the term by up to 5 years . The Company included renewal options that are reasonably certain to be exercised as part of the lease term. Additionally, some lease contracts include termination options. The Company does not expect to exercise the majority of termination options and generally excludes such options when determining the term of leases. The operating lease costs were $ 0.5 million and $ 0.3 million for the three months ended March 31, 2022 and 2021, respectively. The weighted average remaining lease term was 6.33 years and 6.68 years as of March 31, 2022 and December 31, 2021, respectively. The weighted average discount rate was 7.34 % as of each of March 31, 2022 and December 31, 2021. Cash flows arising from lease transactions for the three months ended March 31, 2022 and 2021 were as follows (in thousands): in thousands 2022 2021 Cash paid for amounts included in the measurements of lease liabilities — operating cash flows $ ( 460 ) $ ( 10 ) Right-of-use assets obtained in exchange for operating leases liabilities $ 251 $ — Future minimum lease payments under non-cancellable leases in effect as of March 31, 2022 are as follows (in thousands): Year Ended December 31, Operating 2022 (remainder) $ 1,412 2023 1,790 2024 1,677 2025 1,655 2026 1,642 Thereafter 2,840 Total future undiscounted minimum lease payments $ 11,016 Less: imputed Interest 2,187 Total reported lease liability $ 8,829

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 10 — Fair Value Measurements The Company measures its financial assets and liabilities at fair value each reporting period using a fair value hierarchy that prioritizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Three levels of inputs may be used to measure fair value, as follows: Level 1 Observable inputs, such as quoted prices in active markets for identical assets or liabilities; Level 2 Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and Level 3 Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. The Company uses the market approach to measure fair value for its financial assets and liabilities. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. The carrying amounts of Company's financial instruments, which include cash equivalents, accounts receivable, prepaid expenses, other current assets, accounts payable, accrued liabilities and certain other current liabilities approximate fair value because of their short-term maturities. The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis (in thousands): As of March 31, 2022 Description Level 1 Level 2 Level 3 Total Assets Cash equivalents: Money market account $ 6,102 $ — $ — $ 6,102 Marketable securities US Treasury securities 22,975 — — 22,975 Corporate Debt securities — 24,232 — 24,232 Commercial Paper — 35,887 — 35,887 Asset Backed Securities — 10,575 — 10,575 Total financial assets $ 29,077 $ 70,694 $ - $ 99,771 Liabilities: Contingent consideration $ — $ — $ 29,200 $ 29,200 Total financial liabilities $ — $ — $ 29,200 $ 29,200 As of December 31, 2021 Description Level 1 Level 2 Level 3 Total Assets Cash equivalents: Money market account $ 100,000 $ — $ — $ 100,000 Total financial assets $ 100,000 $ — $ — $ 100,000 Liabilities: Contingent consideration $ — $ — $ 13,700 $ 13,700 Total financial liabilities $ — $ — $ 13,700 $ 13,700 The following table presents a summary of the changes in fair value of the Company's Level 3 financial instruments: in thousands Contingent Consideration Fair value as of December 31, 2021 $ 13,700 Loss on change in fair value of contingent consideration 15,500 Fair value as of March 31, 2022 $ 29,200 The fair value of contingent consideration related to Apollo acquisition is classified as Level 3 financial instruments. To determine the fair value of the contingent consideration, the Company used a Monte Carlo simulation model. The Monte Carlo simulation considered assumptions including revenue volatilities, risk free rates, discount rates and additional revenue discount rate. Additionally, other key assumptions included forecasted revenues from new customers and probability of achieving it. The following table sets forth the range of inputs for the significant assumptions utilized to determine the fair value of contingent consideration as of March 31, 2022: As of March 31, 2022 As of December 31, 2021 Risk-free interest rate 1.62 % 0.56 % Expected revenue volatility 18.5 % 20.0 % Revenue discount rate 6.50 % 5.50 % Discount rate 3.50 % 3.25 %

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 11 — Commitments and Contingencies Legal Proceedings The Company is party to ordinary and routine litigation incidental to its business. On a case-by-case basis, the Company engages inside and outside counsel to assess the probability of potential liability resulting from such litigation. After making such assessments, the Company makes an accrual for the estimated loss only when the loss is probable, and an amount can be reasonably estimated. On February 9, 2022, a putative class action was filed in the United States District Court for the Eastern District of New York styled Artery v. Astra Space, Inc. et al., Case No. 1:22-cv-00737 (E.D.N.Y.) (the “Artery Action”). The complaint alleges that the Company and certain of its current and former officers violated provisions of the Securities Exchange Act of 1934 with respect to certain statements concerning the Company's capabilities and business prospects. The complaint seeks unspecified damages on behalf of a purported class of purchasers of the Company's securities between February 2, 2021 and December 29, 2021. On March 23, 2022, a second putative class action was filed in the United States District Court for the Eastern District of New York styled Riley v. Astra Space, Inc., et al., Case No. 1:22-cv-01591 (E.D.N.Y.) (the “Riley Action,” with the Artery Action, the “Securities Actions”). The Riley Action alleges the same claims, based upon similar facts, against the same defendants, and seeks the same damages. The Company expects that the two cases will be consolidated into a single action. Defendants intend to move to dismiss once the Court appoints a lead plaintiff and an amended complaint is filed. The Company believes that the Securities Actions are without merit and intend to defend them vigorously. Due to the early stage of the cases, neither the likelihood that a loss, if any, will be realized, nor an estimate of the possible loss or range of loss, if any, can be determined. On March 8, 2022, a stockholder derivative suit was filed in the United States District Court for the State of Delaware styled Meyer, et al., v. Kemp, et al., Case No. 22-cv-00308 (D. Del.). The complaint asserts claims against the current members of our board of directors and certain of our current and former officers, for breach of their fiduciary duty, waste, unjust enrichment, and contribution under the Securities Exchange Act of 1934, based upon the conduct alleged in the Artery Action. The plaintiffs seek monetary damages in favor of the Company in an unstated amount, reformation of the Company’s corporate governance and internal procedures, restitution including a disgorgement of any compensation, profits or other benefits achieved, and reimbursement of the plaintiffs’ reasonable fees and costs, including attorney's fees. The Company believes that the case is without merit and intends to defend it vigorously. Due to the early stage of the case, neither the likelihood that a loss, if any, will be realized, nor an estimate of the possible loss or range of loss, if any, can be determined. The Company has tendered defense of each of the three foregoing claims under its Directors' and Officers’ policy. The retention under this policy is $ 20 million. Purchase Commitments On May 25, 2021, the Company entered a contract with a supplier to purchase components. The Company is obligated to purchase $ 22.5 million of components over 60 months. The Company may terminate the supply agreement by paying 50 % of the remaining purchase commitment at any point during the contract term. The Company made total purchases of $ 0.8 million under the contract of which $ 0.4 million related to purchases made during the three months ended March 31, 2022. The Company also made advance payments of $ 0.4 million under the contract during the three months ended March 31, 2022.

Convertible Preferred Stock

Convertible Preferred Stock	3 Months Ended
	Mar. 31, 2022
Equity [Abstract]
Convertible Preferred Stock	Note 12 — Convertible Preferred Stock Convertible Preferred Stock From pre-combination Astra’s inception until the consummation of the Business Combination, approximately $ 100.2 million of cash capital contributions was raised, net of issuance costs, through the issuance of three rounds of convertible preferred equity. The three classes of convertible preferred stock of pre-combination Astra were: Series A convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the “Convertible Preferred Stock”). Immediately before the consummation of the Business Combination, the Convertible Preferred Stock of pre-combination Astra consisted of: Series Shares Outstanding (pre-combination Astra) Liquidation Conversion Annual A 65,780,540 $ 0.243233 $ 0.243233 $ 0.019459 B 70,713,123 1.333008 1.333008 0.106640 C 50,483,785 6.620970 6.620970 0.529680 Total 186,977,448 Upon the consummation of the Business Combination in June 2021, 186,977,448 shares of Convertible Preferred Stock (pre-combination Astra) converted into 124,340,003 shares of Class A common stock of the Company. The Company no longer had Convertible Preferred Stock authorized, issued or outstanding subsequent to the close of Business Combination in June 2021. On January 28, 2021, concurrent with Series C Financing, the Company amended its certificate of incorporation to add a merger with a special purpose acquisition company (“SPAC Transaction”) as one of the defined Deemed Liquidation events. In addition, upon triggering of the Deemed Liquidation events, the holders of the Convertible Preferred Stock were entitled to receive the greater of their liquidation preference per share and the as converted value per share. As of March 31, 2021, the Company assessed the probability of a SPAC Transaction to be probable and therefore, the Convertible Preferred Stock were considered probable of becoming redeemable. Subsequent measurement of Convertible Preferred Stock was then required for the three months ended March 31, 2021. The Company elected to apply the current redemption value method to measure the redeemable Convertible Preferred Stock. Under the method, changes in the redemption value were recognized immediately as they occurred and the carrying value of the Convertible Preferred Stock was adjusted to the redemption value at the end of each reporting date. In the absence of retained earnings, adjustments to redemption value were recorded against additional paid-in capital, if any, and then to accumulated deficit. As of March 31, 2021, adjustments to the carrying amount of the Convertible Preferred Stock of $ 1.1 billion, reflecting the estimated redemption value of $ 7.18 per share as of March 31, 2021, were treated as deemed dividends and were recognized against additional paid-in capital and accumulated deficit on the consolidated balance sheet. On the Closing Date of the Business Combination, all outstanding Convertible Preferred Stock converted into Class A common stock of the Company, therefore, the Company applied conversion accounting to derecognize the existing carrying amount of the Convertible Preferred Stock and increased additional paid-in capital.

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Mar. 31, 2022
Stockholders' Equity Note [Abstract]
Stockholders' Equity	Note 13 — Stockholders’ Equity Common and Preferred Stock As of March 31, 2022, the Company had authorized a total of 466,000,000 shares of stock, consisting of (i) 400,000,000 shares of Class A common stock, par value $ 0.0001 per share (“Class A common stock”), (ii) 65,000,000 shares of Class B common stock, par value $ 0.0001 per share (“Class B common stock”), and (iii) 1,000,000 shares of preferred stock, par value $ 0.0001 per share (“Preferred Stock”). As of March 31, 2022, the Company had 208,610,490 and 55,539,188 shares of Class A and Class B common stock issued and outstanding, respectively. There were no shares of preferred stock outstanding as of March 31, 2022. Holders of the Class A and Class B common stock have identical distribution rights, except that holders of the Class A common stock are entitled to one vote per share and holders of the Class B common stock are entitled to ten votes per share. Each share of Class B common stock can be converted into one share of Class A common stock at any time at the option of the stockholder and automatically convert upon sale or transfer, except for certain transfers specified in the Company's amended and restated certificate of incorporation. In connection with the Business Combination, the Company’s executive officers and founders, Chris Kemp and Adam London, converted an aggregate 10,870,562 shares of Founders Preferred Stock and an aggregate 3,599,647 shares of Class A common stock of pre-combination Astra, which were entitled to one vote per share, into 9,622,689 shares of Class B common stock of the Company, which are entitled to ten votes per share. Founders Convertible Preferred Stock The Company issued 18,500,000 shares of pre-combination Astra’s Founders Convertible Preferred Stock in 2016. Upon vesting, the compensation expense associated with the Founders Convertible Preferred Stock was recorded as stock-based compensation based on the fair value of the Founders Convertible Preferred Stock on the grant date fair value. Immediately before the closing of the Business Combination, 10,870,562 shares of pre-combination Astra’s Founders Convertible Preferred Stock were outstanding. Upon closing of the Business Combination, the shares of Founders Convertible Preferred Stock were converted into shares of Class B common stock of the Company, which are entitled to ten votes per share. Refer to Note 3 – Acquisitions.

Stock-based Compensation

Stock-based Compensation	3 Months Ended
	Mar. 31, 2022
Share-based Payment Arrangement [Abstract]
Share-based Payment Arrangement	Note 14 — Stock-based Compensation Stock-based incentive awards are provided to employees under the terms of various Astra equity incentive plans. 2021 Omnibus Incentive Plan In June 2021, the Board of Directors approved the 2021 Omnibus Incentive Plan (the “2021 Plan”), which reserved 36.8 million shares of Class A common stock for issuance for awards in accordance with the terms of the 2021 Plan. On January 1, 2022, pursuant to the terms of the 2021 Plan, the number of shares of Class A common stock available for issuance under the 2021 Plan increased by 13.1 million. Similarly, the share reserve increases on January 1 of each year from 2023 to 2031 by the lesser of (i) 5 % of the sum of number of shares of (x) Class A common stock and (y) Class B common stock outstanding as of the close of business on the immediately preceding December 31 and (ii) the number of shares of Class A common stock as determined by the Board. The purpose of the 2021 Plan is to advance the Company’s interests by providing for the grant to employees, directors, consultants and advisors of stock and stock-based awards. As of March 31, 2022, 17.5 million shares remain available for issuance under the plan. 2021 Employee Stock Purchase Plan In June 2021, the Board of Directors approved the 2021 Employee Stock Purchase Plan (the “2021 ESPP”) to reserve 5 million shares of Class A common stock for issuance for awards in accordance with the terms of the ESPP. On January 1, 2022, pursuant to the terms of the 2021 ESPP, the number of shares of Class A common stock available for issuance under the 2021 ESPP increased by 2.6 million. Similarly, the number of shares of Class A common stock reserved for issuance under the 2021 ESPP will ultimately increase on January 1 of each year from 2023 to 2031 by the lesser of (i) 1 % of the sum of number of shares of Class A common stock and Class B common stock outstanding as of the close of business on the immediately preceding December 31 and (ii) the number of shares of Class A common stock as determined by the Board. The purpose of the 2021 ESPP is to enable eligible employees to use payroll deductions to purchase shares of Class A common stock and thereby acquire an interest in the company. Eligible employees are offered shares through a 24 -month offering period, which consists of four consecutive 6-month purchase periods. Employees may purchase a limited amount of shares of our stock at a discount of up to 15 % of the lesser of the fair market value at the beginning of the offering period or the end of each 6-month purchase period. 151,644 shares were issued under the Employee Stock Purchase Plan during the three months ended March 31, 2022. As of March 31, 2022, 7.5 million shares remain available for issuance under the 2021 ESPP. As of March 31, 2022, the Company had $ 1.7 million of unrecognized stock-based compensation expense related to the 2021 ESPP. This cost is expected to be recognized over a weighted-average period of 1.24 years. 2016 Equity Incentive Plan In 2016, pre-combination Astra adopted the 2016 Equity Incentive Plan (the “2016 Plan”). Under this Plan, the Board of Directors or a committee appointed by the Board of Directors is authorized to provide stock-based compensation in the form of stock options, stock appreciation rights, restricted stock, and other performance or value-based awards within parameters set forth in the Plan to employees, directors, and non-employee consultants. In connection with the Business Combination, the Company assumed the 2016 Plan upon closing. Each outstanding and unexercised option (“Astra Option”) was converted, at the exchange ratio established in the BCA, into an option (“New Astra Option”) to acquire shares of the Company’s Class A common stock with the same terms and conditions as applicable to the Astra Option immediately prior to the Business Combination. As of March 31, 2022, there were no shares available for issuance under the plan. The following table summarizes stock-based compensation expense that the Company recorded in the condensed consolidated statements of operations for the three months ended March 31, 2022 and 2021: For The Three Months in thousands 2022 2021 Cost of revenues $ 241 $ — Research and development 6,736 3,179 Sales and marketing 1,580 13 General and administrative 8,484 7,141 Stock-based compensation expense $ 17,041 $ 10,333 On November 22, 2021, under the 2021 Plan, the Company's compensation committee issued 1,047,115 PSUs to the employees of Apollo who joined Astra. PSUs are subject to certain performance-based and service-based vesting conditions and would vest over four years with 25% of awards vesting on July 1, 2022, and the remaining 75% vesting quarterly over the remaining 12 quarters beginning on November 15, 2022, only for the portion of PSUs that is eligible to become vested which will be determined based upon timely satisfaction of performance conditions. The number of PSUs vested will be determined by multiplying the total number of PSUs granted by the percentage of milestones achieved and by the percentage of PSUs that satisfy the time-based vesting condition on such time-vesting date. Certain performance conditions for PSUs are subjective and the number of PSUs related to these performance conditions do not meet the criteria for the grant date. Accordingly, 523,557 PSUs and 52,355 PSUs related to the performance conditions that are not subjective are considered granted as of November 22, 2021 and January 21, 2022, respectively. The remaining PSUs issued did not meet the grant date criteria as of March 31, 2022. The Company will re-assess at the end of each reporting period if any further PSUs has met the grant date criteria and account for it in the period in which it meets the grant date criteria. As of March 31, 2022, the Company assessed the probability of success for the performance conditions that are not subjective and determined that the Company has achieved certain of these performance conditions within the requisite period. Therefore, the Company recognized $ 1.0 million compensation costs related to PSUs for the three months ended March 31, 2022. On September 20, 2021, under the 2021 Plan, the Company’s compensation committee granted 3,972,185 restricted stock units (“RSUs”), 3,426,094 time-based stock options and 13,016,178 performance stock options ("PSOs") to its executive officers. RSUs and time-based stock options granted have service-based vesting conditions only. The service conditions vary for each executive officer and is based on their continued service to the Company. Option holders have a 10-year period to exercise their options before options expire. Forfeitures are recognized in the period of occurrence and stock-based compensation costs are recognized based on grant-date fair value as RSUs and time-based stock options vest. PSOs, only eligible to the executive officers of the Company, are subject to performance conditions as follows, and the milestones do not need to be achieved in any specific order or sequence: Milestone A: The Company has had a successful orbital delivery. Milestone B: The Company has had six orbital launches during a six consecutive month period. Milestone C: The Company has completed a prototype for a spacecraft that has achieved an orbital launch. Milestone D: The Company has conducted twenty-six orbital launches during a six consecutive month period. Milestone E: The Company has achieved an orbital launch for an aggregate of 100 spacecraft. These PSOs also require the volume weighted average share price for a period of thirty trading days meet share price thresholds of $15.00, $20.00, $30.00, $40.00 and $50.00 following the achievement of the first milestone, second milestone, third milestone, fourth milestone and fifth milestone, respectively, before a milestone will be deemed achieved. After each milestone is achieved, 20 % of the PSOs will vest on the vesting date immediately following the date at which the price thresholds are met. For this purpose, a "vesting date" is February 15, May 15, August 15 and November 15 of any applicable year. The milestones must be achieved over a period of approximately five years , with the earliest vesting date of November 15, 2022, and the last vesting date no later than November 15, 2026, if all vesting conditions are met. No unvested portion of the PSOs shall vest after November 15, 2026. As of March 31, 2022, the Company assessed the probability of success for the five milestones mentioned above and determined that it is probable that the Company will achieve Milestone A and Milestone B within the requisite period. Therefore, the Company recognized $ 4.9 million compensation costs related to PSOs for the three months ended March 31, 2022. As of March 31, 2022, we had unrecognized stock-based compensation expense of $ 32.8 million for the milestones that were not considered probable of achievement. In February 2021, the Board of Directors approved the acceleration in vesting of 206,250 pre-combination Astra stock options that were issued to one employee on May 15, 2020. The remaining unvested options were fully vested upon acceleration. The Company recorded a $ 1.4 million stock-based compensation expense related to the modification for the three months ended March 31, 2021. As of March 31, 2022, the Company had $ 130.9 million of unrecognized stock-based compensation expense related to all of the Company's stock-based awards. This cost is expected to be recognized over a weighted-average period of 2 .94 years. Secondary Sales In January 2021 , concurrent with Series C Financing, two executive officers, Chris Kemp, founder and Chief Executive Officer (“CEO”), and Adam London, founder and Chief Technology Officer (“CTO”), entered into stock purchase agreements with certain investors including ACME SPV AS, LLC to sell 3,775,879 and 2,265,529 shares, respectively, of Founders Convertible Preferred Stock at purchase prices in excess of the estimated fair value at the time of the transactions (“January 2021 Secondary Sales”) to certain investors. Upon the sale, the Founders Convertible Preferred Stock automatically converted into Series C Convertible Preferred Stock. The Company’s board member, Scott Stanford, is a member of ACME SPV AS, LLC and the Company facilitated the January 2021 Secondary Sales. As a result, for the three months ended March 31, 2021, the Company recorded a total of $ 8.2 million in stock-based compensation expense for the difference between the price paid by these investors and the estimated fair value of the Founders Convertible Preferred Stock on the date of the transaction. Stock Options Awards The following is a summary of stock option activity for the three months ended March 31, 2022: No. of Weighted- Average Exercise Price Weighted- Average Aggregate Intrinsic Outstanding – December 31, 2021 20,326,384 $ 7.52 9.4 $ 22,782,654 Granted 1,142,027 5.21 9.8 Exercised ( 176,774 ) 0.45 4.4 783,216 Forfeited ( 24,661 ) 2.93 — Expired ( 1,465 ) 6.75 — Outstanding – March 31, 2022 21,265,511 $ 7.46 9.2 $ 11,290,701 Unvested – March 31, 2022 18,932,836 8.11 9.3 5,150,439 Exercisable – March 31, 2022 2,332,675 2.12 7.9 6,140,262 The company uses the Black-Scholes option pricing-model to calculate the grant date fair value of time-based options. The following table summarizes the assumptions used in estimating the fair value of options granted in the three months ended March 31, 2022: Time Based Stock Options Expected terms (years) (1) 5.81 Expected volatility (2) 68.9 % Risk-free interest rate (3) 1.70 % Expected dividend rate (4) - Grant-date fair value $ 3.20 ____________ (1) The expected term is the length of time the grant is expected to be outstanding before it is exercised or terminated. This number is calculated as the midpoint between the vesting term and the original contractual term (contractual period to exercise). If the option contains graded vesting, then the vesting term would be based on the vesting pattern. (2) Expected volatility, or the standard deviation of annualized returns, was calculated based on comparable companies’ reported volatilities. (3) Risk-free interest was obtained from US treasury notes for the expected terms noted as of the valuation date . (4) The Company has assumed a dividend yield of zero as it has no plans to declare dividends in the foreseeable future . Restricted Stock Units Awards The following is a summary of restricted stock units for the three months ended March 31, 2022: Number of RSUs Outstanding Weighted- Average Grant Date Fair Value Per Share Outstanding – December 31, 2021 10,678,818 $ 9.20 Granted 3,937,226 4.25 Vested ( 828,680 ) 8.64 Forfeited ( 328,562 ) 9.23 Outstanding – March 31, 2022 13,458,802 $ 7.78 Total fair value as of the respective vesting dates of restricted stock units vested for the three months ended March 31, 2022 was approximately $ 2.9 million. As of March 31, 2022, the aggregate intrinsic value of unvested restricted stock units was $ 51.9 million.

Loss per Share

Loss per Share	3 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Loss per Share	Note 15 — Loss per Share Founders Convertible Preferred Stock and Convertible Preferred Stock were participating securities in periods of income, as the Founders Convertible Preferred Stock and Convertible Preferred Stock participated in undistributed earnings on an as-if-converted or as-vested basis. However, the Founders Convertible Preferred Stock and Convertible Preferred Stock, did not share in losses. The Company computes earnings per share of Common Stock using the two-class method required for participating securities and does not apply the two-class method in periods of net loss. Basic and diluted earnings per share were the same for the periods presented as the inclusion of all potential Common Stock outstanding would have been anti-dilutive. Earnings per share calculations for all periods prior to the Business Combination have been retrospectively restated to the equivalent number of shares reflecting the exchange ratio established in the BCA. Subsequent to the Business Combination, earnings per share was calculated based on weighted average number of shares of common stock then outstanding. The following tables set forth the computation of basic and diluted loss for the three months ended March 31, 2022 and 2021: For The Three Months Ended March 31, 2022 2021 (in thousands, except share and per share amounts) Class A Class B Class A Class B Net loss attributed to common stockholders $ ( 67,657 ) $ ( 18,056 ) $ ( 40,862 ) $ ( 118,110 ) Adjustment to redemption value on Convertible Preferred Stock — — ( 260,051 ) ( 751,675 ) Net loss attributed to common stockholders $ ( 67,657 ) $ ( 18,056 ) $ ( 300,913 ) $ ( 869,785 ) Basic weighted average common shares outstanding 208,112,630 55,539,188 16,206,813 46,845,555 Dilutive weighted average common shares outstanding 208,112,630 55,539,188 16,206,813 46,845,555 Loss per share attributable to common stockholders: Basic and Diluted loss per share $ ( 0.33 ) $ ( 0.33 ) $ ( 18.57 ) $ ( 18.57 ) There were no preferred dividends declared or accumulated as of March 31, 2021. The following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive: As of March 31, 2022 2021 Class A Class B Class A Class B Stock options 8,249,326 — 7,553,987 — RSUs 13,359,326 — — — Convertible Preferred Stock — — 131,568,927 — Warrants — — 480,520 — Total 21,608,652 — 139,603,433 —

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Note 16 — Related Party Transactions Cue Health, Inc. The Company began purchasing COVID-19 test readers and related test cartridges from Cue Health Inc. in the late second quarter 2021, at its standard pricing. In August 2021, the Company entered into a six-month subscription arrangement with Cue Health Inc. for the purchase of COVID-19 test readers and the related test cartridges. Under Cue Health Inc.’s standard subscription arrangement, the Company receives a twenty percent ( 20 %) discount on each Cue Reader and fourteen percent ( 14 %) discount on each test cartridge. Mr. Stanford, a member of the Board and the Company’s Lead Director, serves on the board of directors of Cue Health Inc. Funds affiliated with ACME Capital collectively beneficially own 10.4 % of the outstanding common stock of Cue Health Inc. Mr. Stanford was not involved in the negotiation of the Company’s arrangement with Cue Health Inc. The Company conducted its independent evaluation of Cue’s services and determined in its sole judgment Cue’s product and services were the best option for the Company to ensure it could maintain a safe and productive work environment. The Company made purchases of $ 0.4 million during the three months ended March 31, 2022. No such purchases were made during the three months ended March 31, 2021. Convertible Promissory Notes In June 2019, the Company issued promissory convertible notes to A/NPC Holdings LLC and Sherpa Ventures Fund, II LP for gross proceeds of $ 10.0 million and $ 0.6 million, respectively. In November 2020, the Company issued promissory convertible notes to Sherpa Ventures Fund II, LP and Eagle Creek Capital LLC, for gross proceeds of $ 0.2 million and $ 0.5 million, respectively. Some of the Company’s board members at that time were or are related parties of these entities. Nomi Bergman, who was serving as our director when the promissory convertible notes were issued, is a principal of A/NPC Holdings LLC and Scott Stanford, who serves as our director, is a principal of Sherpa Ventures Fund II, LP and a member of Eagle Creek Capital, LLC. In all instances the terms of these transactions were the same as third-party investors. On January 28, 2021, the Company settled the promissory convertible notes through the issuance of Series C convertible preferred stock. 7,819,887 and 469,193 shares of Series C convertible preferred stock were issued to A/NPC Holdings LLC and Sherpa Ventures Fund II, LP at a per share price of $ 1.33 to settle $ 10.4 million and $ 0.6 million outstanding principal and accrued interest, respectively. Additionally, 264,928 and 115,771 shares of Series C convertible preferred stock were issued to Eagle Creek Capital, LLC and Sherpa Ventures Fund II, LP at a per share price of $ 1.71 to settle $ 0.5 million and $ 0.2 million outstanding principal and accrued interest, respectively. See Note 6 — Long-Term Debt for mechanism of settlement.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	Note 17 — Subsequent Events On April 27, 2022 , a stockholder derivative suit was filed in the United States District Court for the Eastern District of New York styled Gonzalez v. Kemp, et al., Case No. 22-cv-02401 (E.D.N.Y.). The complaint asserts claims against the current members of the Company’s board of directors and certain of its current and former officers for alleged breaches of their fiduciary duties, unjust enrichment, abuse of control, mismanagement, and waste of corporate assets, alleged violations of Section 14(a) of the Securities Exchange Act of 1934 (the "Exchange Act"), and for contribution under Section 10(b) and 21D of the Exchange Act based upon the conduct alleged in the Artery Action described under Note 11— Commitments and Contingencies. The plaintiff seeks monetary damages in favor of the Company in an unstated amount, reforms to the Company’s corporate governance and internal procedures, restitution including disgorgement of any compensation, profits or other benefits received, and reimbursement of the plaintiff's reasonable fees and costs, including attorney's fees. The Company believes that the case is without merit and intends to defend it vigorously. Due to the early stage of the case, neither the likelihood that a loss, if any, will be realized, nor an estimate of the possible loss or range of loss, if any, can be determined.

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of Astra and its subsidiaries, and have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) as determined by the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for financial reporting. The condensed consolidated financial statements included herein are unaudited, and reflect all adjustments which are, in the opinion of management, of a normal recurring nature and necessary for a fair statement of the results for the periods presented. The December 31, 2021 condensed consolidated balance sheet data were derived from Astra’s audited consolidated financial statements included in its Annual Report on Form 10-K for year ended December 31, 2021 as filed with the SEC. All intercompany transactions and balances have been eliminated in consolidation. The operating results for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022, or for any other future period.
Business Combination and Liquidity	Business Combination On June 30, 2021, the Business Combination pursuant to the BCA, by and among Holicity, Merger Sub, and pre-combination Astra, was accounted for as a reverse recapitalization as pre-combination Astra was determined to be the accounting acquirer under ASC 805. The determination is primarily based on the evaluation of the following facts and circumstances: • the equity holders of pre-combination Astra hold the majority of voting rights in the Company; • the board of directors of pre-combination Astra represent a majority of the members of the board of directors of the Company; • the senior management of pre-combination Astra became the senior management of the Company; and • the operations of pre-combination Astra comprise the ongoing operations of the Company. In connection with the Business Combination, outstanding common stock and preferred convertible stock of the pre-combination Astra was converted into common stock of the Company, par value of $ 0.0001 per share, representing a recapitalization, and the net assets of the Company were acquired and recorded at historical cost, with no goodwill or intangible assets recorded. Pre-combination Astra was deemed to be the predecessor and the condensed consolidated assets and liabilities and results of operations prior to the Closing Date are those of pre-combination Astra. Reported shares and earnings per share available to common stockholders, prior to the Business Combination, have been retroactively restated as shares reflecting the exchange ratio established in the BCA. The number of shares of preferred stock was also retroactively restated based on the exchange ratio. See Note 3 — Acquisitions for additional information. Liquidity The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis. The Company has historically funded its operations primarily by equity financings and convertible promissory notes prior to the Business Combination and subsequently funded its operations through cash proceeds obtained as part of the Business Combination and related private placement. As of March 31, 2022, the Company’s existing sources of liquidity included cash and cash equivalents of $ 161.5 million and marketable securities of $ 93.7 million. The Company has a limited history of operations and has incurred negative cash flows from operating activities and loss from operations in the past as reflected in the accumulated deficit of $ 1,494.1 million as of March 31, 2022. The Company expects to continue to incur operating losses due to the investments it intends to make in its business, including the development of its products and services. Management continuously evaluates opportunities to strengthen the Company’s financial position, including through the issuance of additional equity securities or by entering into new financing arrangements, as appropriate. However, the Company has adequate liquidity that it expects will be sufficient to fund operating and capital expenditure requirements through at least twelve (12) months from the date of issuance of these financial statements.
Impact of the COVID-19 Pandemic	Impact of the COVID-19 Pandemic The Company has been actively monitoring the ongoing COVID-19 pandemic situation and its impact on the Company’s business. The COVID-19 pandemic had disrupted everyday life and markets worldwide, leading to significant business and supply-chain disruption, as well as broad-based changes in supply and demand. The Company has been diligent in testing and monitoring our employees, and there have been disruptions in productivity, although these disruptions have not resulted in suspension of our manufacturing facilities. However, beginning in the first quarter of 2021, there has been a trend in many parts of the world of increasing availability and administration of vaccines against COVID-19, as well as an easing of restrictions on social, business, travel and government activities and functions. On the other hand, infection rates and regulations continue to fluctuate in various regions and there are ongoing global impacts resulting from the pandemic, including challenges and increases in costs for logistics and supply chains, such as increased intermittent supplier delays and a shortfall of semiconductor supply. Ultimately, we cannot predict the duration of the COVID-19 pandemic. We will continue to monitor macroeconomic conditions to remain flexible and to optimize and evolve our business as appropriate and deploy our production, workforce and other resources accordingly.
Use of Estimates and Judgements	Use of Estimates and Judgements The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities in the condensed consolidated financial statements and accompanying notes. The Company bases these estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ significantly from those estimates. Significant items subject to such estimates and assumptions include the valuation of goodwill and intangible assets, inventory valuation, stock-based compensation, pre-combination Astra common stock, useful lives of intangible assets and fixed assets, deferred tax assets, income tax uncertainties, contingent consideration and other contingencies.

Acquisitions (Tables)

Acquisitions (Tables)	3 Months Ended
	Mar. 31, 2022
Business Acquisition [Line Items]
Schedule of Number of Shares of Class A Common Stock Issued	The number of shares of Class A common stock issued immediately following the consummation of the Business Combination were: Common stock of Holicity 29,989,019 Holicity founder shares 7,500,000 Shares issued in PIPE 20,000,000 Business Combination and PIPE shares 57,489,019 Pre-combination Astra shares 140,601,884 Total shares of Class A common stock immediately after Business Combination 198,090,903
Apollo Fusion Inc [Member]
Business Acquisition [Line Items]
Schedule of acquisition-date fair value of the consideration transferred	The fair value of the consideration paid as of July 1, 2021, was $ 70.8 million, net of cash acquired (the "Apollo Merger"), which consisted of the following: Purchase Consideration (in thousands) Cash paid for outstanding Apollo common stock and options $ 19,926 Fair value of Astra Class A common stock issued 33,008 Fair value of contingent consideration 18,400 Total purchase consideration 71,334 Less: cash acquired 566 Total purchase consideration, net of cash acquired $ 70,768
Schedule of preliminary allocation of the total purchase price	(in thousands) Fair Value Inventory $ 131 Prepaid and other current assets 796 Property, plant and equipment 996 Right of use assets 163 Goodwill 58,251 Intangible assets 15,350 Other non-current assets 75 Total assets acquired 75,762 Accounts payable ( 950 ) Accrued expenses and other current liabilities ( 1,939 ) Operating lease obligation ( 163 ) Other non-current liabilities ( 1,942 ) Total liabilities assumed ( 4,994 ) Fair value of net assets acquired $ 70,768
Schedule of Intangible Assets Fair Value and Amortization Periods	Intangible Assets Fair Value Weighted-Average Amortization Periods (in thousands) (in years) Developed technology $ 12,100 6 Customer contracts and related relationships 2,900 3 Order backlog 200 1 Tradename 150 2 Total identified intangible assets $ 15,350

Property, Plant and Equipment,N

Property, Plant and Equipment,Net (Tables)	3 Months Ended
	Mar. 31, 2022
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment, Net	Property, Plant and Equipment, net Presented in the table below are the major classes of property, plant and equipment: in thousands As of March 31, 2022 As of December 31, 2021 Construction in progress $ 9,693 $ 39,246 Computer and software 3,418 3,092 Leasehold improvements 54,343 14,177 Research equipment 11,716 8,935 Production equipment 11,746 10,442 Furniture and fixtures 1,035 1,001 Total property, plant and equipment 91,951 76,893 Less: accumulated depreciation ( 12,536 ) ( 10,577 ) Property, plant and equipment, net $ 79,415 $ 66,316

Intangible Assets (Tables)

Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of Other Intangible Assets	in thousands Carrying Amount Accumulated Amortization Net Book Value As of March 31, 2021: Definite-lived intangible assets Developed technology $ 12,100 $ 1,513 $ 10,587 Customer contracts and related relationship 2,900 725 2,175 Order backlog 200 150 50 Trade names 150 56 94 Intangible assets subject to amortization 15,350 2,444 12,906 Indefinite-lived intangible assets Trademarks 4,200 — 4,200 Total $ 19,550 $ 2,444 $ 17,106 in thousands Carrying Amount Accumulated Amortization Net Book Value As of December 31, 2021: Definite-lived intangible assets Developed technology $ 12,100 $ 1,008 $ 11,092 Customer contracts and related relationship 2,900 483 2,417 Order backlog 200 100 100 Trade names 150 38 112 Intangible assets subject to amortization 15,350 1,629 13,721 Indefinite-lived intangible assets Trademarks 4,200 — 4,200 Total $ 19,550 $ 1,629 $ 17,921
Expected Future Amortization Expense Related to Intangible Assets	Based on the amount of intangible assets as of March 31, 2022, the expected amortization expense for each of the next five years and thereafter is as follows: in thousands Expected Amortization Expense 2022 (remainder) $ 2,343 2023 3,021 2024 2,500 2025 2,017 2026 2,017 Thereafter 1,008 Total intangible assets $ 12,906

Supplemental Financial Inform_2

Supplemental Financial Information (Tables)	3 Months Ended
	Mar. 31, 2022
Supplemental Financial Information Abstract
Inventory	Inventories in thousands As of March 31, 2022 As of December 31, 2021 Raw materials $ 8,032 $ 5,775 Work in progress 669 941 Finished goods — 959 Inventories $ 8,701 $ 7,675
Schedule of Major Classes of Property Plant And Equipment	Property, Plant and Equipment, net Presented in the table below are the major classes of property, plant and equipment: in thousands As of March 31, 2022 As of December 31, 2021 Construction in progress $ 9,693 $ 39,246 Computer and software 3,418 3,092 Leasehold improvements 54,343 14,177 Research equipment 11,716 8,935 Production equipment 11,746 10,442 Furniture and fixtures 1,035 1,001 Total property, plant and equipment 91,951 76,893 Less: accumulated depreciation ( 12,536 ) ( 10,577 ) Property, plant and equipment, net $ 79,415 $ 66,316
Accrued Expenses and Other Current Liabilities	Accrued Expenses and Other Current Liabilities in thousands As of March 31, 2022 As of December 31, 2021 Employee compensation and benefits $ 6,516 $ 9,927 Contract liabilities, current portion 10,307 10,162 Fair value of contingent consideration, current portion 3,500 — Construction in progress related accruals 1,365 3,726 Accrued expenses 4,837 3,464 Other (miscellaneous) 2,793 2,620 Accrued expenses and other current liabilities $ 29,318 $ 29,899
Other Non-Current Liabilities	Other Non-Current Liabilities in thousands As of March 31, 2022 As of December 31, 2021 Fair value of contingent consideration, net of current portion $ 25,700 $ 13,700 Contract liabilities, net of current portion 149 149 Other (miscellaneous) 1,250 750 Other non-current liabilities $ 27,099 $ 14,599

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2022
Leases [Abstract]
Schedule of Supplemental Cash Flow Information	Cash flows arising from lease transactions for the three months ended March 31, 2022 and 2021 were as follows (in thousands): in thousands 2022 2021 Cash paid for amounts included in the measurements of lease liabilities — operating cash flows $ ( 460 ) $ ( 10 ) Right-of-use assets obtained in exchange for operating leases liabilities $ 251 $ —
Schedule of Future Minimum Lease Payments under Non-cancellable Lease Payments	Future minimum lease payments under non-cancellable leases in effect as of March 31, 2022 are as follows (in thousands): Year Ended December 31, Operating 2022 (remainder) $ 1,412 2023 1,790 2024 1,677 2025 1,655 2026 1,642 Thereafter 2,840 Total future undiscounted minimum lease payments $ 11,016 Less: imputed Interest 2,187 Total reported lease liability $ 8,829

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of fair value hierarchy	The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis (in thousands): As of March 31, 2022 Description Level 1 Level 2 Level 3 Total Assets Cash equivalents: Money market account $ 6,102 $ — $ — $ 6,102 Marketable securities US Treasury securities 22,975 — — 22,975 Corporate Debt securities — 24,232 — 24,232 Commercial Paper — 35,887 — 35,887 Asset Backed Securities — 10,575 — 10,575 Total financial assets $ 29,077 $ 70,694 $ - $ 99,771 Liabilities: Contingent consideration $ — $ — $ 29,200 $ 29,200 Total financial liabilities $ — $ — $ 29,200 $ 29,200 As of December 31, 2021 Description Level 1 Level 2 Level 3 Total Assets Cash equivalents: Money market account $ 100,000 $ — $ — $ 100,000 Total financial assets $ 100,000 $ — $ — $ 100,000 Liabilities: Contingent consideration $ — $ — $ 13,700 $ 13,700 Total financial liabilities $ — $ — $ 13,700 $ 13,700
Summary of the Changes In Fair Value of Financial Instruments	The following table presents a summary of the changes in fair value of the Company's Level 3 financial instruments: in thousands Contingent Consideration Fair value as of December 31, 2021 $ 13,700 Loss on change in fair value of contingent consideration 15,500 Fair value as of March 31, 2022 $ 29,200
Summary of Range of Inputs To Determine The Fair Value of Contingent Consideration	The following table sets forth the range of inputs for the significant assumptions utilized to determine the fair value of contingent consideration as of March 31, 2022: As of March 31, 2022 As of December 31, 2021 Risk-free interest rate 1.62 % 0.56 % Expected revenue volatility 18.5 % 20.0 % Revenue discount rate 6.50 % 5.50 % Discount rate 3.50 % 3.25 %

Convertible Preferred Stock (Ta

Convertible Preferred Stock (Tables)	3 Months Ended
	Mar. 31, 2022
Equity [Abstract]
Schedule of Three Classes of Convertible Preferred Stock Before Combination	The three classes of convertible preferred stock of pre-combination Astra were: Series A convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the “Convertible Preferred Stock”). Immediately before the consummation of the Business Combination, the Convertible Preferred Stock of pre-combination Astra consisted of: Series Shares Outstanding (pre-combination Astra) Liquidation Conversion Annual A 65,780,540 $ 0.243233 $ 0.243233 $ 0.019459 B 70,713,123 1.333008 1.333008 0.106640 C 50,483,785 6.620970 6.620970 0.529680 Total 186,977,448

Stock-based Compensation (Table

Stock-based Compensation (Tables)	3 Months Ended
	Mar. 31, 2022
Share-based Payment Arrangement [Abstract]
Summary of Share-based Compensation	For The Three Months in thousands 2022 2021 Cost of revenues $ 241 $ — Research and development 6,736 3,179 Sales and marketing 1,580 13 General and administrative 8,484 7,141 Stock-based compensation expense $ 17,041 $ 10,333
Summary of Stock Option Activity	No. of Weighted- Average Exercise Price Weighted- Average Aggregate Intrinsic Outstanding – December 31, 2021 20,326,384 $ 7.52 9.4 $ 22,782,654 Granted 1,142,027 5.21 9.8 Exercised ( 176,774 ) 0.45 4.4 783,216 Forfeited ( 24,661 ) 2.93 — Expired ( 1,465 ) 6.75 — Outstanding – March 31, 2022 21,265,511 $ 7.46 9.2 $ 11,290,701 Unvested – March 31, 2022 18,932,836 8.11 9.3 5,150,439 Exercisable – March 31, 2022 2,332,675 2.12 7.9 6,140,262 The company uses the Black-Scholes option pricing-model to calculate the grant date fair value of time-based options. The following table summarizes the assumptions used in estimating the fair value of options granted in the three months ended March 31, 2022: Time Based Stock Options Expected terms (years) (1) 5.81 Expected volatility (2) 68.9 % Risk-free interest rate (3) 1.70 % Expected dividend rate (4) - Grant-date fair value $ 3.20 ____________ (1) The expected term is the length of time the grant is expected to be outstanding before it is exercised or terminated. This number is calculated as the midpoint between the vesting term and the original contractual term (contractual period to exercise). If the option contains graded vesting, then the vesting term would be based on the vesting pattern. (2) Expected volatility, or the standard deviation of annualized returns, was calculated based on comparable companies’ reported volatilities. (3) Risk-free interest was obtained from US treasury notes for the expected terms noted as of the valuation date . (4) The Company has assumed a dividend yield of zero as it has no plans to declare dividends in the foreseeable future .
Summary of restricted stock units	The following is a summary of restricted stock units for the three months ended March 31, 2022: Number of RSUs Outstanding Weighted- Average Grant Date Fair Value Per Share Outstanding – December 31, 2021 10,678,818 $ 9.20 Granted 3,937,226 4.25 Vested ( 828,680 ) 8.64 Forfeited ( 328,562 ) 9.23 Outstanding – March 31, 2022 13,458,802 $ 7.78

Loss per Share (Tables)

Loss per Share (Tables)	3 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Schedule of Computation of Basic and Diluted Loss	The following tables set forth the computation of basic and diluted loss for the three months ended March 31, 2022 and 2021: For The Three Months Ended March 31, 2022 2021 (in thousands, except share and per share amounts) Class A Class B Class A Class B Net loss attributed to common stockholders $ ( 67,657 ) $ ( 18,056 ) $ ( 40,862 ) $ ( 118,110 ) Adjustment to redemption value on Convertible Preferred Stock — — ( 260,051 ) ( 751,675 ) Net loss attributed to common stockholders $ ( 67,657 ) $ ( 18,056 ) $ ( 300,913 ) $ ( 869,785 ) Basic weighted average common shares outstanding 208,112,630 55,539,188 16,206,813 46,845,555 Dilutive weighted average common shares outstanding 208,112,630 55,539,188 16,206,813 46,845,555 Loss per share attributable to common stockholders: Basic and Diluted loss per share $ ( 0.33 ) $ ( 0.33 ) $ ( 18.57 ) $ ( 18.57 )
Schedule of Antidilutive Shares	There were no preferred dividends declared or accumulated as of March 31, 2021. The following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive: As of March 31, 2022 2021 Class A Class B Class A Class B Stock options 8,249,326 — 7,553,987 — RSUs 13,359,326 — — — Convertible Preferred Stock — — 131,568,927 — Warrants — — 480,520 — Total 21,608,652 — 139,603,433 —

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies - Additional information (Detail) - USD ($) $ / shares in Units, $ in Thousands	Jul. 01, 2021	Nov. 30, 2020	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Accounting Policy [Line Items]
Cash and cash equivalents			$ 161,521		$ 325,007
Marketable securities			93,700
Accumulated deficit			(1,494,096)		(1,408,383)
Revenue recognized				$ 2,300
Contract liabilities			10,500		$ 10,400
Other income, net			400	0
Unsatisfied performance obligations			23,800
Loss on extinguishment of convertible notes			0	(131,908)
Research and development			$ 37,927	12,196
Apollo Fusion Inc [Member]
Accounting Policy [Line Items]
Total purchase consideration, net of cash acquired	$ 70,768
October 2019 Convertible Notes [Member]
Accounting Policy [Line Items]
Loss on extinguishment of convertible notes		$ 600		$ (133,800)
Exchange of Stock for Stock [Member]
Accounting Policy [Line Items]
Common stock, par value			$ 0.0001

Revenues - Additional Informati

Revenues - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Revenues [Abstract]
Contract liabilities	$ 10,500		$ 10,400
Unsatisfied performance obligations	23,800
recognized revenue under launch and space products agreements	3,900	$ 0
Revenue recognized		2,300
Other income (expense), net	$ 400	$ 0

Acquisitions - Additional Infor

Acquisitions - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands	Nov. 22, 2021	Jul. 01, 2021	Mar. 31, 2022	Mar. 31, 2021	Jun. 30, 2021	Dec. 31, 2021	Dec. 26, 2021
Business Combination Segment Allocation [Line Items]
Contingent consideration liability upon acquisition			$ 29,200
Common stock, shares issued							3,775,709
Decrease in fair value of contingent consideration liability			(15,500)	$ 0
Loss on change in fair value of contingent consideration			15,500	0
General and administrative expenses			20,986	$ 12,394
Transaction cost					$ 25,200
Additional paid in capital			1,862,709			$ 1,844,875
Private Placement Warrants [Member]
Business Combination Segment Allocation [Line Items]
Redeemed price per share					$ 10
Holicity S Trust | Executive Officer | Common Stock [Member]
Business Combination Segment Allocation [Line Items]
Business combination share issued in exchange of number of share					73,699,647
Holicity S Trust | Founder | Preferred Stock
Business Combination Segment Allocation [Line Items]
Business combination share issued in exchange of number of share					10,870,562
PSUs [Member]
Business Combination Segment Allocation [Line Items]
Number of shares issued to employees	1,047,115
Holicity Inc
Business Combination Segment Allocation [Line Items]
Common stock, par value					$ 0.0001
Business Combination Share Exchange Ratio					approximately one pre-combination Astra share to 0.665 of the Company's shares
Cash and Cash Equivalents, Period Increase (Decrease)					$ 463,600
Proceeds from Issuance of Private Placement					$ 200,000
Business combination share issued					29,989,019
Business combination share redeemed					10,981
Redeemed price per share					$ 10
Holicity Inc | Private Placement Warrants [Member]
Business Combination Segment Allocation [Line Items]
Business combination share issued					20,000,000
Holicity Inc | Founder
Business Combination Segment Allocation [Line Items]
Business combination share issued					7,500,000
Apollo Fusion Inc [Member]
Business Combination Segment Allocation [Line Items]
Total purchase consideration, net of cash acquired		$ 70,768
Maximum contingent consideration		$ 75,000
Business Combination Contingent Consideration Arrangements Revenue Under Contract Percentage		25.00%
Fair value of contingent consideration		$ 18,400
Fair value of contingent consideration		71,334
Revenues			0
Decrease in fair value of contingent consideration liability			(10,800)
Loss on change in fair value of contingent consideration			10,800
Acquisition in cash						10,000
Accrued expenses and other current liabilities			3,400			$ 3,900
Compensation Cost		7,100	$ 1,300
Apollo Fusion Inc [Member] | Fair Value, Inputs, Level 3 [Member]
Business Combination Segment Allocation [Line Items]
Fair value of contingent consideration		$ 18,400
Common Class A [Member]
Business Combination Segment Allocation [Line Items]
Common stock, shares issued			208,610,490			207,451,107
Common stock, shares outstanding			208,610,490			207,451,107
Common stock, par value			$ 0.0001			$ 0.0001
Common Class A [Member] | Holicity Inc
Business Combination Segment Allocation [Line Items]
Common stock, shares issued					198,090,903
Common stock, shares outstanding					198,090,903
Aggregate stock option to purchase					5,993,412
Warrants to purchase common stock					15,813,829
Business combination share issued					198,090,903
Common Class A [Member] | Holicity Inc | Founder
Business Combination Segment Allocation [Line Items]
Business combination share issued					37,489,019
Common Class B [Member]
Business Combination Segment Allocation [Line Items]
Common stock, shares issued			55,539,188			55,539,189
Common stock, shares outstanding			55,539,188			55,539,189
Common stock, par value			$ 0.0001			$ 0.0001
Common Class B [Member] | Holicity Inc
Business Combination Segment Allocation [Line Items]
Common stock, shares issued					56,239,189
Common stock, shares outstanding					56,239,189
Business combination share issued					56,239,189

Acquisitions - Schedule of Acqu

Acquisitions - Schedule of Acquisition-date Fair Value of The Consideration Transferred (Details) - Apollo Fusion Inc [Member] $ in Thousands	Jul. 01, 2021USD ($)
Business Acquisition [Line Items]
Cash paid for outstanding Apollo common stock and options	$ 19,926
Fair value of Astra Class A common stock issued	33,008
Fair value of contingent consideration	18,400
Total purchase consideration	71,334
Less: cash acquired	566
Total purchase consideration, net of cash acquired	$ 70,768

Acquisitions - Schedule of Prel

Acquisitions - Schedule of Preliminary Allocation of The Total Purchase Price (Details) - Apollo Fusion Inc [Member] $ in Thousands	Jul. 01, 2021USD ($)
Business Acquisition [Line Items]
Inventory	$ 131
Prepaid and other current assets	796
Property, plant and equipment	996
Right of use assets	163
Goodwill	58,251
Intangible assets	15,350
Other non-current assets	75
Total assets acquired	75,762
Accounts payable	(950)
Accrued expenses and other current liabilities	(1,939)
Operating lease obligation	(163)
Other non-current liabilities	(1,942)
Total liabilities assumed	(4,994)
Fair value of net assets acquired	$ 70,768

Acquisitions - Schedule of Inta

Acquisitions - Schedule of Intangible Assets Fair Value and Amortization Periods (Details) - Apollo Fusion Inc [Member] $ in Thousands	3 Months Ended
	Mar. 31, 2022USD ($)
Business Acquisition [Line Items]
Total identified intangible assets	$ 15,350
Developed Technology [Member]
Business Acquisition [Line Items]
Total identified intangible assets	$ 12,100
Weighted-Average Amortization Periods	6 years
Customer contracts and related relationships
Business Acquisition [Line Items]
Total identified intangible assets	$ 2,900
Weighted-Average Amortization Periods	3 years
Order Backlog [Member]
Business Acquisition [Line Items]
Total identified intangible assets	$ 200
Weighted-Average Amortization Periods	1 year
Trade Names [Member]
Business Acquisition [Line Items]
Total identified intangible assets	$ 150
Weighted-Average Amortization Periods	2 years

Acquisitions - Schedule of Numb

Acquisitions - Schedule of Number of Shares of Class A Common Stock Issued (Details)	6 Months Ended
	Jun. 30, 2021shares
Holicity Inc
Business Combination Segment Allocation [Line Items]
Business combination share issued	29,989,019
Holicity Inc | Common Class A [Member]
Business Combination Segment Allocation [Line Items]
Business combination share issued	198,090,903
Holicity Inc | Private Placement Warrants [Member]
Business Combination Segment Allocation [Line Items]
Business combination share issued	20,000,000
Holicity Inc | Private Placement Warrants [Member] | Business Combination [Member]
Business Combination Segment Allocation [Line Items]
Business combination share issued	57,489,019
Holicity Inc | Founder
Business Combination Segment Allocation [Line Items]
Business combination share issued	7,500,000
Holicity Inc | Founder | Common Class A [Member]
Business Combination Segment Allocation [Line Items]
Business combination share issued	37,489,019
Astra Space Operations Inc | Pre Combination
Business Combination Segment Allocation [Line Items]
Business combination share issued	140,601,884

Supplemental Financial Inform_3

Supplemental Financial Information - Schedule of Inventory (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Supplemental Financial Information Abstract
Raw materials	$ 8,032	$ 5,775
Work in progress	669	941
Finished goods		959
Inventories, net	$ 8,701	$ 7,675

Supplemental Financial Inform_4

Supplemental Financial Information - Schedule of Property, Plant and Equipment, Net (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Property Plant And Equipment [Line Items]
Total property, plant and equipment	$ 91,951	$ 76,893
Less: accumulated depreciation	(12,536)	(10,577)
Property, plant and equipment, net	79,415	66,316
Construction in Progress [Member]
Property Plant And Equipment [Line Items]
Total property, plant and equipment	9,693	39,246
Computer and Software [Member]
Property Plant And Equipment [Line Items]
Total property, plant and equipment	3,418	3,092
Leasehold Improvements [Member]
Property Plant And Equipment [Line Items]
Total property, plant and equipment	54,343	14,177
Research and Development Equipment [Member]
Property Plant And Equipment [Line Items]
Total property, plant and equipment	11,716	8,935
Production Equipment [Member]
Property Plant And Equipment [Line Items]
Total property, plant and equipment	11,746	10,442
Furniture and Fixtures [Member]
Property Plant And Equipment [Line Items]
Total property, plant and equipment	$ 1,035	$ 1,001

Supplemental Financial Inform_5

Supplemental Financial Information - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Property Plant And Equipment [Line Items]
Depreciation	$ 1,960	$ 888
Inventory net realizable value write downs	5,500	0
Impairment charges	$ 0	$ 0

Supplemental Financial Inform_6

Supplemental Financial Information - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Other Liabilities, Current [Abstract]
Employee compensation and benefits	$ 6,516	$ 9,927
Contract liabilities, current portion	10,307	10,162
Fair value of contingent consideration, current portion	3,500
Construction in progress gross	1,365	3,726
Accrued expenses	4,837	3,464
Other (miscellaneous)	2,793	2,620
Accrued expenses and other current liabilities	$ 29,318	$ 29,899

Supplemental Financial Inform_7

Supplemental Financial Information - Schedule of Other Non Current Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Accrued Liabilities and Other Liabilities [Abstract]
Fair value of contingent consideration	$ 25,700	$ 13,700
Contract liabilities	149	149
Other (miscellaneous)	1,250	750
Other non-current liabilities	$ 27,099	$ 14,599

Intangible Assets - Summary of

Intangible Assets - Summary of Intangible Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Intangible assets subject to amortization, gross		$ 15,350	$ 15,350
Intangible assets subject to amortization, accumulated amortization		1,629	2,444
Total intangible assets	$ 12,906	13,721	12,906
Total intangible assets, Carrying amount		19,550	19,550
Total intangible assets	$ 17,106	17,921	17,106
Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets subject to amortization, gross		4,200	4,200
Total intangible assets		4,200	4,200
Developed Technology [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets subject to amortization, gross		12,100	12,100
Intangible assets subject to amortization, accumulated amortization		1,008	1,513
Total intangible assets		11,092	10,587
Customer Contracts And Related Relationship [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets subject to amortization, gross		2,900	2,900
Intangible assets subject to amortization, accumulated amortization		483	725
Total intangible assets		2,417	2,175
Order Backlog [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets subject to amortization, gross		200	200
Intangible assets subject to amortization, accumulated amortization		100	150
Total intangible assets		100	50
Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets subject to amortization, gross		150	150
Intangible assets subject to amortization, accumulated amortization		38	56
Total intangible assets		$ 112	$ 94

Intangible Assets - Expected Fu

Intangible Assets - Expected Future Amortization Expense Related to Intangible Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
2022 (remainder)	$ 2,343
2023	3,021
2024	2,500
2025	2,017
2026	2,017
Thereafter	1,008
Total intangible assets	$ 12,906	$ 13,721	$ 12,906

Long Term Debt - Additional Inf

Long Term Debt - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands	Jan. 28, 2021	Dec. 25, 2018	Nov. 30, 2020	Apr. 20, 2020	Jun. 30, 2019	Mar. 31, 2022	Mar. 31, 2021	Sep. 30, 2021	Dec. 26, 2021	Jun. 30, 2021
Debt Instrument [Line Items]
Common stock, shares issued									3,775,709
Warrants exercise price per share						$ 11.50			$ 11.50
Warrant exercisable period		10 years
Loss on extinguishment of convertible notes						$ 0	$ 131,908
Series C Preferred Stock [Member]
Debt Instrument [Line Items]
Conversion Of Stock Amount Issued1	$ 61,000
Equity Financing Yield					$ 20,000
Cash Purchase Price Per Share	$ 6.62
Conversion of Stock, Shares Issued	38,323,292
Maximum [Member] | Series C Preferred Stock [Member]
Debt Instrument [Line Items]
Debt Instrument, Convertible, Conversion Price										$ 1.71
Minimum [Member] | Series C Preferred Stock [Member]
Debt Instrument [Line Items]
Debt Instrument, Convertible, Conversion Price										$ 1.33
June 2019 Convertible Notes [Member]
Debt Instrument [Line Items]
Conversion Of Stock Amount Issued1								$ 14,800
Debt Instrument Maturity Date								Jun. 10, 2021
Convertible Notes Payable										$ 14,500
June 2019 Convertible Notes [Member] | Maximum [Member]
Debt Instrument [Line Items]
Long Term Debt Percentage Bearing Fixed Interest Rate								2.37%
June 2019 Convertible Notes [Member] | Minimum [Member]
Debt Instrument [Line Items]
Long Term Debt Percentage Bearing Fixed Interest Rate								2.13%
October 2019 Convertible Notes [Member]
Debt Instrument [Line Items]
Conversion Of Stock Amount Issued1								$ 45,000
Cash Purchase Price Per Share	$ 6.62
Convertible Notes Payable						43,200
Derecognition Of Convertible Notes Payable						42,600
Loss on extinguishment of convertible notes			$ (600)				$ 133,800
October 2019 Convertible Notes [Member] | Series C Preferred Stock [Member]
Debt Instrument [Line Items]
Conversion Of Stock Amount Issued1						$ 176,900
Conversion of Stock, Shares Issued						26,727,308
October 2019 Convertible Notes [Member] | Maximum [Member]
Debt Instrument [Line Items]
Long Term Debt Percentage Bearing Fixed Interest Rate								1.69%
October 2019 Convertible Notes [Member] | Minimum [Member]
Debt Instrument [Line Items]
Long Term Debt Percentage Bearing Fixed Interest Rate								1.59%
Paycheck Protection Program Note [Member]
Debt Instrument [Line Items]
Proceeds from loan				$ 4,900
Warrant [Member]
Debt Instrument [Line Items]
Common stock, shares issued		480,520
Warrants exercise price per share		$ 0.24
2018 Term Loan [Member]
Debt Instrument [Line Items]
Maximum borrowing capacity, amount		$ 3,000
2018 Equipment Advances [Member]
Debt Instrument [Line Items]
Maximum borrowing capacity, amount		$ 7,000

Warrant Liabilities - Additiona

Warrant Liabilities - Additional Information (Details)	Dec. 27, 2021$ / sharesshares	Dec. 26, 2021$ / sharesshares	Mar. 31, 2022$ / sharesshares	Dec. 26, 2021$ / sharesshares	Dec. 31, 2021shares	Dec. 31, 2020$ / sharesshares
Class of Warrant or Right [Line Items]
Warrants exercise price per share | $ / shares		$ 11.50	$ 11.50	$ 11.50
Percentage of number of shares			50.00%
Common stock, shares issued		3,775,709		3,775,709
Temporary Equity, Redemption Price Per Share | $ / shares	$ 0.10
Share Price | $ / shares	$ 10
Common Class A [Member]
Class of Warrant or Right [Line Items]
Common stock, shares issued			208,610,490		207,451,107
Shares to be received for each redeemable warrants		0.002560374
IPOMember
Class of Warrant or Right [Line Items]
Class of Warrant or Right, Outstanding						9,999,976
Warrants exercise price per share | $ / shares						$ 11.50
Public Warrants [Member]
Class of Warrant or Right [Line Items]
Number of warrants exercised		9,413,895
Number of warrants redeemed	586,075
Private Placement Warrants [Member]
Class of Warrant or Right [Line Items]
Sale of Stock, Number of Shares Issued in Transaction			5,333,333	5,333,333

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Tax Disclosure [Abstract]
Income tax (benefit) expense	$ 0	$ 0

Leases - Additional Information

Leases - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Lessee Lease Description [Line Items]
Operating lease term, option to extend additional period	5 years
Lessee, Operating Lease, Description	The Company has operating leases for warehouse, production, and office facilities and equipment. Lease contracts have remaining lease terms of less than one year to seven years, some of which include options to extend the term by up to 5 years. The Company included renewal options that are reasonably certain to be exercised as part of the lease term. Additionally, some lease contracts include termination options. The Company does not expect to exercise the majority of termination options and generally excludes such options when determining the term of leases.
Operating lease, weighted average remaining lease term	6 years 3 months 29 days		6 years 8 months 4 days
Operating lease, weighted average discount rate	7.34%		7.34%
Operating Lease, Cost	$ 0.5	$ 0.3
Minimum [Member]
Lessee Lease Description [Line Items]
Operating lease,remaining term	1 year
Maximum [Member]
Lessee Lease Description [Line Items]
Operating lease,remaining term	7 years

Leases - Components of Lease Co

Leases - Components of Lease Costs (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Leases [Abstract]
Operating lease costs	$ 0.5	$ 0.3

Leases - Schedule of Supplement

Leases - Schedule of Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash paid for amounts included in the measurements of lease liabilities:
Cash paid for amounts included in the measurements of lease liabilities, operating cash flows	$ 460	$ 10
Right-of-use assets obtained in exchange for operating leases liabilities	$ 251

Leases - Schedule of Future Min

Leases - Schedule of Future Minimum Lease Payments under Non-cancellable Lease Payments (Details) $ in Thousands	Mar. 31, 2022USD ($)
Leases [Abstract]
2022 (remainder)	$ 1,412
2023	1,790
2024	1,677
2025	1,655
2026	1,642
Thereafter	2,840
Total future undiscounted minimum lease payments	11,016
Less: Imputed Interest	2,187
Total reported lease liability	$ 8,829

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of fair value hierarchy (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Assets:
Total financial assets	$ 99,771	$ 100,000
Liabilities:
Total financial liabilities	29,200	13,700
Contingent Consideration [Member]
Liabilities:
Total financial liabilities	29,200	13,700
Level 1 [Member]
Assets:
Total financial assets	29,077	100,000
Liabilities:
Total financial liabilities	0	0
Level 1 [Member] | Contingent Consideration [Member]
Liabilities:
Total financial liabilities	0	0
Level 2 [Member]
Assets:
Total financial assets	70,694	0
Liabilities:
Total financial liabilities	0	0
Level 2 [Member] | Contingent Consideration [Member]
Liabilities:
Total financial liabilities	0	0
Level 3 [Member]
Assets:
Total financial assets	0	0
Liabilities:
Total financial liabilities	29,200	13,700
Level 3 [Member] | Contingent Consideration [Member]
Liabilities:
Total financial liabilities	29,200	13,700
Money market account
Assets:
Total financial assets	6,102	100,000
Money market account | Level 1 [Member]
Assets:
Total financial assets	6,102	100,000
Money market account | Level 2 [Member]
Assets:
Total financial assets	0	0
Money market account | Level 3 [Member]
Assets:
Total financial assets	0	$ 0
US Treasury securities
Assets:
Total financial assets	22,975
US Treasury securities | Level 1 [Member]
Assets:
Total financial assets	22,975
US Treasury securities | Level 2 [Member]
Assets:
Total financial assets	0
US Treasury securities | Level 3 [Member]
Assets:
Total financial assets	0
Corporate Debt securities
Assets:
Total financial assets	24,232
Corporate Debt securities | Level 1 [Member]
Assets:
Total financial assets	0
Corporate Debt securities | Level 2 [Member]
Assets:
Total financial assets	24,232
Corporate Debt securities | Level 3 [Member]
Assets:
Total financial assets	0
Commercial Paper
Assets:
Total financial assets	35,887
Commercial Paper | Level 1 [Member]
Assets:
Total financial assets	0
Commercial Paper | Level 2 [Member]
Assets:
Total financial assets	35,887
Commercial Paper | Level 3 [Member]
Assets:
Total financial assets	0
Asset Backed Securities
Assets:
Total financial assets	10,575
Asset Backed Securities | Level 1 [Member]
Assets:
Total financial assets	0
Asset Backed Securities | Level 2 [Member]
Assets:
Total financial assets	10,575
Asset Backed Securities | Level 3 [Member]
Assets:
Total financial assets	$ 0

Fair Value Measurements - Summa

Fair Value Measurements - Summary of the Changes In Fair Value of the Company Financial Instruments (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2022USD ($)
Fair Value Disclosures [Abstract]
Fair value as of December 31, 2021	$ 13,700
Loss on change in fair value of contingent consideration included in operating loss	15,500
Fair value as of March 31, 2022	$ 29,200

Fair Value Measurements - Sch_2

Fair Value Measurements - Schedule of Range of Inputs To Determine The fair Value of Contingent Consideration (Details)	Mar. 31, 2022	Dec. 31, 2021
Risk-free interest rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent Consideration	1.62	0.56
Expected revenue volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent Consideration	18.5	20
Revenue discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent Consideration	6.50	5.50
Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent Consideration	3.50	3.25

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Millions	May 05, 2021	Mar. 31, 2022	Mar. 08, 2022	May 25, 2021
Commitments and Contingencies Disclosure [Abstract]
Purchase Obligation, to be Paid, Year Two and Three				$ 22.5
Payments for purchase of other assets	$ 0.8	$ 0.4
Percentage of remaining purchase commitment during contract term				50.00%
Retention costs payable			$ 20
AdvancePaymentsOfPurchase		$ 0.4

Convertible Preferred Stock - A

Convertible Preferred Stock - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Preferred stock, shares outstanding	0
Pre Combination Astra
Preferred stock, shares outstanding	186,977,448
Convertible Preferred Stock [Member]
Cash capital contributions since inception	$ 100,200,000
Preferred stock, shares outstanding	0		0
Redeemable Noncontrolling Interest, Equity, Preferred, Redemption Value		$ 7,180
Adjustments to the carrying amount of the Convertible Preferred Stock		$ 1,100,000,000
Convertible Preferred Stock [Member] | Pre Combination Astra
Preferred stock, shares outstanding	186,977,448
Common Class A [Member]
Convertible preferred stock, shares issued upon conversion	124,340,003

Convertible Preferred Stock - S

Convertible Preferred Stock - Schedule of Three Classes of Convertible Preferred Stock Before Combination (Details)	Mar. 31, 2022$ / sharesshares
Preferred stock, shares outstanding | shares	0
Pre Combination Astra
Preferred stock, shares outstanding | shares	186,977,448
Pre Combination Astra | Series A Preferred Stock [Member]
Preferred stock, shares outstanding | shares	65,780,540
Liquidation Price Per Share	$ 0.243233
Annual Noncumulative Dividend Rights Per Share	0.019459
Conversion Price Per Share	$ 0.243233
Pre Combination Astra | Series B Preferred Stock [Member]
Preferred stock, shares outstanding | shares	70,713,123
Liquidation Price Per Share	$ 1.333008
Annual Noncumulative Dividend Rights Per Share	0.106640
Conversion Price Per Share	$ 1.333008
Pre Combination Astra | Series C Preferred Stock [Member]
Preferred stock, shares outstanding | shares	50,483,785
Liquidation Price Per Share	$ 6.620970
Annual Noncumulative Dividend Rights Per Share	0.529680
Conversion Price Per Share	$ 6.620970

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Detail) - $ / shares	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Dec. 26, 2021	Dec. 31, 2016
Common stock, shares authorized	466,000,000
Common stock, shares issued			3,775,709
Preferred stock, shares outstanding	0
Founders Preferred Stock [Member]
Pre- combination preferred stock, shares outstanding	10,870,562
Common Class A [Member]
Common stock, shares authorized	400,000,000	400,000,000
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares issued	208,610,490	207,451,107
Common stock, shares outstanding	208,610,490	207,451,107
Pre- combination preferred stock, shares outstanding	3,599,647
Voting rights per share	one
Common Class B [Member]
Common stock, shares authorized	65,000,000	65,000,000
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares issued	55,539,188	55,539,189
Common stock, shares outstanding	55,539,188	55,539,189
Pre- combination preferred stock, shares outstanding	9,622,689
Voting rights per share	ten
Convertible Preferred Stock [Member]
Preference shares authorized	1,000,000	1,000,000
Preference shares, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares outstanding	0	0
Convertible Preferred Stock [Member] | Astra’s Founders [Member]
Preferred stock, shares outstanding	10,870,562			18,500,000
Voting rights per share	ten
Preferred Stock [Member]
Preference shares authorized	1,000,000
Preference shares, par value (in Dollars per share)	$ 0.0001

Stock-based Compensation - Summ

Stock-based Compensation - Summary of Share-based Compensation (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation	$ 17,041	$ 10,333
Research and Development [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation	6,736	3,179
Cost of revenues [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation	241
Sales and Marketing [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation	1,580	13
General and Administrative [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation	$ 8,484	$ 7,141

Stock-based Compensation - Addi

Stock-based Compensation - Additional Information (Details)	Jan. 21, 2022shares	Nov. 22, 2021shares	Sep. 20, 2021shares	Jan. 28, 2021RelatedParties$ / sharesshares	Feb. 28, 2021USD ($)	Mar. 31, 2022USD ($)$ / sharesshares	Mar. 31, 2021USD ($)	Jun. 30, 2021shares	Sep. 30, 2021	Jan. 01, 2022shares
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation						$ 17,041,000	$ 10,333,000
Number of related party | RelatedParties				2
Stock options issuance date				Jan. 28, 2021
Unrecognized share based compensation expense						$ 32,800,000
Award granted | shares						1,142,027
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period						10 years
Unrecognized Stock Based Compensation Expense						$ 1,700
Aggregate Intrinsic value exercised						783,216,000
Stock-based compensation						17,041,000	10,333,000
Stock Based Compensation Expense Modification Related						1,400,000
Unvested aggregate intrinsic value						5,150,439,000
Series C Preferred Stock [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Cash Purchase Price Per Share | $ / shares				$ 6.62
Stock-Based Awards [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Unrecognized share based compensation expense						$ 130,900,000
Weighted average period expected to be recognized						2 years 11 months 8 days
Restricted Stock Units (RSUs) [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Total fair value as of the respective vesting dates of restricted stock units vested						$ 2,900,000
Shares vested, Grant date fair value | $ / shares						$ 8.64
Unvested aggregate intrinsic value						$ 51,900,000
Performance Based Stock Option [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Vesting periods						5 years
Vesting Percentage						20.00%
Stock-based compensation						$ 4,900,000
PSUs [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Award granted | shares	52,355	523,557
Number of shares issued to employees | shares		1,047,115
Description of PSUs vesting period						PSUs are subject to certain performance-based and service-based vesting conditions and would vest over four years with 25% of awards vesting on July 1, 2022, and the remaining 75% vesting quarterly over the remaining 12 quarters beginning on November 15, 2022, only for the portion of PSUs that is eligible to become vested which will be determined based upon timely satisfaction of performance conditions.
Compensation costs						$ 1,000,000
Employee [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Total fair value as of the respective vesting dates of restricted stock units vested					$ 206,250,000
Executive Officer | Restricted Stock Units (RSUs) [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Award granted | shares			3,972,185
Executive Officer | Performance Based Stock Option [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Award granted | shares			13,016,178
Executive Officer | Time Based Stock Options [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Award granted | shares			3,426,094
Chief Executive Officer [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Share-based accelerated vesting stock options | shares				3,775,879
Chief Technology Officer [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Share-based accelerated vesting stock options | shares				2,265,529
General and Administrative Expense [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation						8,484,000	7,141,000
2021 Omnibus Incentive Plan [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Increase in number of common shares reserved for future issuance | shares										13,100,000
Percentage of Sum of Number of Shares								5.00%
Remain available for issuance						17,500,000
2021 Omnibus Incentive Plan [Member] | Common Class A [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance | shares								36,800,000
2021 Omnibus Incentive Plan [Member] | PSUs [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Number of shares issued to employees | shares		1,047,115
2021 Omnibus Incentive Plan [Member] | Minimum [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Award Issuance Year									2023
2021 Omnibus Incentive Plan [Member] | Maximum [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Award Issuance Year									2031
2021 Employee Stock Purchase Plan [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Increase in number of common shares reserved for future issuance | shares										2.6
Percentage of Sum of Number of Shares								1.00%
Remain available for issuance						$ 7,500,000
Eligible Employees Shares Offering Period								24 months
Discount on Shares Purchased								15.00%
Shares Issued | shares						151,644
Cost Over Weighted Average Period						1 year 2 months 26 days
2021 Employee Stock Purchase Plan [Member] | Common Class A [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance | shares								5,000,000
2021 Employee Stock Purchase Plan [Member] | Minimum [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Award Issuance Year									2023
2021 Employee Stock Purchase Plan [Member] | Maximum [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Award Issuance Year									2031
Secondary Sales [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation							$ 8,200,000

Stock-based Compensation - Su_2

Stock-based Compensation - Summary of stock option activity (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Share-based Payment Arrangement [Abstract]
Options outstanding Beginning balance, Shares	20,326,384
Options outstanding, Granted	1,142,027
Options outstanding, Exercised	(176,774)
Options outstanding, Forfeited	(24,661)
Options outstanding, Expired	(1,465)
Options Outstanding, Ending balance, Shares	21,265,511	20,326,384
Unvested, Ending balance	18,932,836
Exercisable, Ending balance	2,332,675
Options outstanding Beginning balance, Shares	$ 7.52
Options outstanding, Granted	5.21
Options Outstanding, Exercised	0.45
Options outstanding, Forfeited	2.93
Options outstanding, Expired	6.75
Options Outstanding, Ending balance, Shares	7.46	$ 7.52
Weighted- Average Exercise Price - Unvested	8.11
Exercisable – June 30, 2021	$ 2.12
Weighted average remaining term, outstanding	9 years 2 months 12 days	9 years 4 months 24 days
Weighted average remaining term, exercised	4 years 4 months 24 days
Aggregate Intrinsic value exercised	$ 783,216
Weighted Average Remaining Term Granted	9 years 9 months 18 days
Weighted- Average Remaining Term Unvested	9 years 3 months 18 days
Weighted Average Remaining Term, Exercisable	7 years 10 months 24 days
Outstanding aggregate intrinsic value, Beginning balance	$ 22,782,654
Outstanding aggregate intrinsic value, Ending balance	11,290,701	$ 22,782,654
Unvested aggregate intrinsic value	5,150,439
Exercisable December 31,2021	$ 6,140,262

Stock-based Compensation - Su_3

Stock-based Compensation - Summary of fair value of options granted (Details) - Time Based Options	3 Months Ended
	Mar. 31, 2022$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected terms (years)	5 years 9 months 21 days	[1]
Expected volatility	68.90%	[2]
Risk-free interest rate	1.70%	[3]
Expected dividend rate	0.00%	[4]
Grant-date fair value	$ 3.20
[1]	The expected term is the length of time the grant is expected to be outstanding before it is exercised or terminated. This number is calculated as the midpoint between the vesting term and the original contractual term (contractual period to exercise). If the option contains graded vesting, then the vesting term would be based on the vesting pattern.
[2]	Expected volatility, or the standard deviation of annualized returns, was calculated based on comparable companies’ reported volatilities.
[3]	Risk-free interest was obtained from US treasury notes for the expected terms noted as of the valuation date
[4]	The Company has assumed a dividend yield of zero as it has no plans to declare dividends in the foreseeable future

Stock-based Compensation - Su_4

Stock-based Compensation - Summary of restricted stock units (Details)	3 Months Ended
	Mar. 31, 2022$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding, beginning balance | shares	10,678,818
RSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of RSUs Outstanding Granted | shares	3,937,226
Number of RSUs Outstanding, Vested | shares	828,680
Number of RSUs Outstanding, Forfeited | shares	328,562
Outstanding, ending balance | shares	13,458,802
Weighted- Average Grant Date Fair Value Per Share, Beginning balance | $ / shares	$ 9.20
Grant-date fair value | $ / shares	4.25
Weighted Average Grant Date Fair Value Per Share, Vested | $ / shares	8.64
Weighted Average Grant Date Fair Value Per Share, Forfeited | $ / shares	9.23
Weighted- Average Grant Date Fair Value Per Share, Ending balance | $ / shares	$ 7.78

Loss per Share - Schedule of Co

Loss per Share - Schedule of Computation of Basic and Diluted Loss (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Net loss attributed to common stockholders	$ (85,713)	$ (1,170,698)
Adjustment to redemption value on Convertible Preferred Stock		(1,011,726)
Common Class A [Member]
Net loss attributed to common stockholders	(67,657)	(300,913)
Gross loss	(67,657)	(40,862)
Adjustment to redemption value on Convertible Preferred Stock	$ 0	$ (260,051)
Basic weighted average common shares outstanding	208,112,630	16,206,813
Dilutive weighted average common shares outstanding	208,112,630	16,206,813
Net loss per share:
Basic and Diluted loss per share	$ (0.33)	$ (18.57)
Common Class B [Member]
Net loss attributed to common stockholders	$ (18,056)	$ (869,785)
Gross loss	(18,056)	(118,110)
Adjustment to redemption value on Convertible Preferred Stock	$ 0	$ (751,675)
Basic weighted average common shares outstanding	55,539,188	46,845,555
Dilutive weighted average common shares outstanding	55,539,188	46,845,555
Net loss per share:
Basic and Diluted loss per share	$ (0.33)	$ (18.57)

Loss per Share - Additional Inf

Loss per Share - Additional Information (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2021USD ($)
Earnings Per Share [Abstract]
Preferred dividends declared	$ 0

Loss per Share - Schedule of _2

Loss per Share - Schedule of Computation of diluted Shares Outstanding (Details) - shares	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Common Class A [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Total	21,608,652	139,603,433
Common Class A [Member] | RSUs [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Total	13,359,326	0
Common Class A [Member] | Stock Options [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Total	8,249,326	7,553,987
Common Class A [Member] | Convertible Preferred Stock [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Total	0	131,568,927
Common Class A [Member] | Warrant [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Total	0	480,520
Common Class B [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Total	0	0
Common Class B [Member] | RSUs [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Total	0	0
Common Class B [Member] | Stock Options [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Total	0	0
Common Class B [Member] | Convertible Preferred Stock [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Total	0	0
Common Class B [Member] | Warrant [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Total	0	0

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands	Jan. 28, 2021	Nov. 30, 2020	Jun. 30, 2019	Mar. 31, 2022	Mar. 31, 2021
Defined Benefit Plan Disclosure [Line Items]
Award granted				1,142,027
Stock-based compensation				$ 17,041	$ 10,333
RSUs [Member]
Defined Benefit Plan Disclosure [Line Items]
Value of RSUs				$ 2,900
A/NPC Holdings LLC | Series C Convertible Preferred Stock [Member]
Defined Benefit Plan Disclosure [Line Items]
Issuance of preferred stock	7,819,887
A/NPC Holdings LLC | Promissory Convertible Notes [Member]
Defined Benefit Plan Disclosure [Line Items]
Gross proceeds			$ 10,000
Sherpa Venture Fund II LP | Series C Convertible Preferred Stock [Member]
Defined Benefit Plan Disclosure [Line Items]
Issuance of preferred stock	469,193			115,771
Sherpa Venture Fund II LP | Promissory Convertible Notes [Member]
Defined Benefit Plan Disclosure [Line Items]
Gross proceeds		$ 200	$ 600
Eagle Creek Capital LLC | Series C Convertible Preferred Stock [Member]
Defined Benefit Plan Disclosure [Line Items]
Issuance of preferred stock				264,928
Eagle Creek Capital LLC | Promissory Convertible Notes [Member]
Defined Benefit Plan Disclosure [Line Items]
Gross proceeds		$ 500
ANPC Holdings LLC and Sherpa Venture Fund LP
Defined Benefit Plan Disclosure [Line Items]
Outstanding interest	$ 600
ANPC Holdings LLC and Sherpa Venture Fund LP | Series C Convertible Preferred Stock [Member]
Defined Benefit Plan Disclosure [Line Items]
Shares issued price per share	$ 1.33
Outstanding principal	$ 10,400
Eagle Creek Capital LLC and Sherpa Venture Fund LP | Series C Convertible Preferred Stock [Member]
Defined Benefit Plan Disclosure [Line Items]
Shares issued price per share	$ 1.71
Outstanding principal	$ 500
Outstanding interest	$ 200
Cue Health, Inc. [Member]
Defined Benefit Plan Disclosure [Line Items]
Total purchase amount				$ 400	$ 0
Outstanding common stock owned by director, percentage				10.40%
Cue Health, Inc. [Member] | COVID-19 Test Cartridges [Member]
Defined Benefit Plan Disclosure [Line Items]
Discount on subscription arrangement				14.00%
Cue Health, Inc. [Member] | COVID-19 Test Readers [Member]
Defined Benefit Plan Disclosure [Line Items]
Discount on subscription arrangement				20.00%

Subsequent Events - Additional

Subsequent Events - Additional Information (Details) - Subsequent Event [Member]	Apr. 27, 2022
Subsequent Event [Line Items]
Subsequent Event, Date	Apr. 27, 2022
Subsequent Event, Description	The complaint asserts claims against the current members of the Company’s board of directors and certain of its current and former officers for alleged breaches of their fiduciary duties, unjust enrichment, abuse of control, mismanagement, and waste of corporate assets, alleged violations of Section 14(a) of the Securities Exchange Act of 1934 (the "Exchange Act"), and for contribution under Section 10(b) and 21D of the Exchange Act based upon the conduct alleged in the Artery Action